In vitro and in vivo characterization of neural progenitor cells as putative candidates for experimental studies and clinical trials in cell replacement therapy for neurodegenerative diseases by Hovakimyan, Marine (gnd: 138627258)
  
 
In vitro and in vivo characterization of neural progenitor cells as 
putative candidates for experimental studies and clinical trials in cell 
replacement therapy for neurodegenerative diseases 
 
 
 
 
 
Dissertation 
zur 
Erlangung des akademischen Grades 
Doctor rerum naturalium (Dr. rer. nat.) 
der Mathematisch-Naturwissenschaftlichen Fakultät 
der Universität Rostock 
 
 
 
 
vorgelegt von 
Marine Hovakimyan 
geboren am 28.10.1977 in Armenien 
 
Rostock, September 2008 
 
urn:nbn:de:gbv:28-diss2009-0119-0 
 
 
 
 1. Gutachter: Prof. Dr. med. Oliver Schmitt (Institut für Anatomie, Medizinische Fakultät der 
Universität Rostock) 
 
2. Gutachter: Prof. Dr. rer. nat. Dieter G. Weiss (Institut für Biowissenschaften, Matematisch-
Naturwissenschaftliche Fakultät der Universität Rostock) 
 
3. Gutachter: Prof. Dr. med. vet. Ingo Nolte (Klinik für Kleintiere, Tierärztliche Hochschule 
Hannover) 
 
 
 
 
Das wissenschaftliche Kolloquium fand am 08.06.2009 statt. 
 1
Content 
Content…………………………………………………………………………………………......... 
 
 
1 
Abbreviations………………………………………………………………………………………... 
 
 
2 
Abstract…………………………………………………………………………………………….... 
 
 
4 
General outline of the thesis…………………………………………………………………............ 
 
 
5 
Chapter 1: General introduction…………………………………………………………………....... 
 
6 
     1.1 Neurodegenerative disorders and fetal transplantation……………………………………… 
 
6 
     1.2 Stem and progenitor cells…………………………………………………………………….. 
 
8 
     1.3 In vitro expansion of neural progenitor cells……………………………………………….... 
 
 
9 
Chapter 2: General results and discussion…………………………………………………………... 
 
14 
      2.1 In vitro characterization of the striatal neuronal precursor cell line ST14A……………….... 
 
14 
      2.2 In vitro characterization of mesencephalic hNPCs………………………………………….. 
 
16 
      2.3 In vivo characterization of in vitro expanded hNPCs………………………………………. 
 
 
18 
References…………………………………………………………………………………………… 
 
 
23 
Chapter 3: Publications: Reprints …………………………………………………………………... 
 
 
33 
Declaration on contribution to publications ………………………………………………………… 
 
 
34 
Acknowledgments…………………………………………………………………………………… 
 
 
35 
Curriculum vitae…………………………………………………………………………………...... 
 
36 
 2
Abbreviations 
BDNF  brain-derived neurotrophic factor 
BMP  bone morhpogenic protein 
CAG  cytosine-adenine-guanine 
c-myc  myelocystomatosis cellular oncogene 
CNS  central nervous system  
CNTF  ciliary neurotrophic factor 
CSF  colony stimulating factor  
Cy A  cyclosporin A  
DA  dopamine 
DAergic  dopaminergic 
EGF  epidermal growth factor  
EPO  erythropoetin 
ES cell  embryonic stem cell 
FGF-2  fibroblast growth factor 2 
GABAergic gamma aminobutyric acid-ergic 
GDNF  glial cell-line derived neurotrophic factor 
GFAP  glial fibrillary acidic protein 
HD  Huntington’s disease 
hNPCs  human neural progenitor cells 
IFN  interferon 
IL  interleukin 
ir  immunoreactive 
L-DOPA  L-3,4-dioxyphenylalanine 
LIF  leukaemia inhibitory factor 
MAP2  microtubule-associated protein 2 
MAP5  microtubule-associated protein 5 
MFB  medial forebrain bundle 
NeuN  neuronal nuclei
NF160  neurofilament 160 kDa 
NF200  neurofilament 200 kDa 
NGF  nerve growth factor 
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NSE  neuron specific enolase 
NPCs  neural progenitor cells 
NSCs  neural stem cells 
NT3  neurotrophin 3 
6-OHDA  6-hydroxydopamine 
PD  Parkinson’s disease 
PDGF  platelet-derived growth factor 
p75NGFR  nerve growth factor receptor p75
RNA  ribonucleic acid 
RT-PCR  real time polymerase chain reaction  
SN  substantia nigra 
SV40  Simian-Virus-40 
SVZ subventricular zone 
TGF  and transforming growth factor alpha 
TH  tyrosine hydroxylase 
TNF  tumour necrosis factor 
TrkA  tropomyosin-related kinase A 
TrkB  tropomyosin-related kinase B 
TrkC  tropomyosin-related kinase C 
VM  ventral mesencephalon 
v-myc  myelocytomatosis viral oncogene 
VZ  ventricular zone 
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Abstract 
There is increasing interest towards in vitro expanded neural progenitor cells (NPCs) as 
promising candidates for cell replacement therapy in neurodegenerative diseases. In vitro 
properties of rat fetal conditionally immortalized striatal cells ST14A and human NPCs (hNPCs) 
derived from the mesencephalic area of an 8-week-old embryo have been investigated in this 
study. ST14A cells showed a high proliferative ability and expression of neural progenitor cell 
(NPCs) markers nestin and vimentin at permissive temperature of 33 C. In contrast, at the 
nonpermissive temperature of 39 C, cell proliferation was ceased, nestin and vimentin 
expression was decreased, and cells underwent neuronal differentiation. The cells were, however, 
immunoreactive (ir) only for neuronal markers typical for immature neurons, lacking expression 
of mature neuronal markers. It has been concluded, that for further application for transplantation 
purposes into animals, these cells have to be induced to produce a mature neuronal phenotype. In 
contrast, hNPCs showed in vitro proliferation only in presence of growth factors when expanded 
as free-floating neurospheres. They stopped to proliferate after removal of growth factors, and 
differentiated in tyrosine hydroxylase (TH)-expressing neurons. When transplanted into 
hemiparkinsonian neonatal and adult rat striatum, hNPCs survive even in the absence of 
immunosupression, and ameliorate motor deficits caused by lesion, as shown by two behavioural 
tests: apomorphine-induced rotation and the cylinder test. However, surivival, and migration of 
grafted hNPCs differed in neonatal and adult rats: cells survived much better in neonate animals, 
and migration distance was also longer in neonates. In neonatal rats hNPCs underwent 
differentiation into neurons, among these TH-expressing, and astroglia. In contrast, in adult ones 
no TH differentiation was observed, although most of the cells differentiatied into neurons and 
astrocytes. 
Both tests showed a behavioural recovery in transplanted animals (neonates as well as adults) in 
contrast to sham-operated ones. The presence of significant behavioural recovery even in absence 
of dopaminergic differentiation in adult animals indicates that not only TH-expressing, but other 
types of neurons, and astrocytes also might contribute to amelioration of motor deficits. 
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General outline of the thesis 
This thesis consists of three chapters, with a general introduction at the beginning (Chapter 1). 
Results and their discussion are presented in the chapter 2. The reprints of all three publications 
are presented in the chapter 3. The cells derived from embryonic rat striatum (Publication 1) and 
human embryonic VM (Publications 2 and 3) were expanded in vitro and their proliferation and 
differentiation capacities have been evaluated. Cells derived from these two brain areas were 
chosen as they are of special interest as putative candidates for preclinical experiments and 
clinical trials for the treatment of two common, wide-spread neurodegenerative disorders, 
Parkinson’s and Huntington’s diseases. The in vitro observations concerning hNPCs were 
followed by the transplantation studies (Publications 2 and 3). The survival, migration and 
differentiation of hNPCs were evaluated after grafting into neonatal (Publication 2) and adult 
(Publication 3) striatum of hemiparkinsonian rats. 
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Chapter 1: General introduction 
1.1. Neurodegenerative disorders and fetal transplantation 
Neurodegenerative diseases are an assortment of central nervous system (CNS) disorders, 
characterized by neuronal loss in the different brain areas. 
Although neurodegenerative diseases have different causes, the dysfunction and loss of certain 
groups of neurons is common to all these disorders and allows the development of similar 
therapeutic strategies for their treatment. 
Parkinson’s disease (PD) is the second most-common neurodegenerative disease of genetic, toxic 
as well as slow progressing idiopathic ethiology affecting around 2% of the population over 65 
years of age (Roybon et al., 2004). The disorder was originally described by James Parkinson in 
1817 (Parkinson 1817). The pathological hallmarks include progressive loss of dopaminergic 
(DAergic) projection neurons in the substantia nigra pars compacta (SN) and cytoplasmatic 
inclusions called Lewy bodies (Dawson and Dawson, 2003). The following depletion of 
dopamine (DA) transmitter in the striatum is clinically associated most often with tremor, 
rigidity, progressive bradykinesia and postural instability (Tedroff, 1999). Idiopathic PD 
symptoms become apparent when about 50% of nigral DAergic neurons and 70-80% of striatal 
dopamine are lost (Dunnett and Björklund, 1999). Pharmacological treatment with L-DOPA (L-
3,4-dioxyphenylalanine) works initially, but is often related to undesirable side effects, including 
motor complications. 
Likewise, currently no pharmacological treatment exists for another neurological disorder, 
Huntington’s disease (HD). First described by George Huntington in 1872, HD is a relatively 
common hereditary neurological disease, caused by the expansion of a CAG (cytosine-adenine-
guanine) triplet repeat in the huntington gene, resulting in the selective dysfunction and loss of 
gamma aminobutyric acid-ergic (GABAergic) neurons in the striatum which project to the globus 
pallidus and SN. Clinically, the disease presents with progressive motor, emotional and cognitive 
disturbances until death within 15 to 20 years (Ona et al., 1999). No specific treatment is known 
to slow, stop or reverse the progressive nature of the disease. 
Functional replacement of specific neuronal populations through transplantation of neural tissue 
represents an attractive therapeutic strategy for treating neurodegenerative disorders such as HD 
and PD. Given that most neurodegenerative diseases affect the neuronal populations of specific 
neurochemical phenotypes, an ideal source material for transplantation would be a cell capable to 
limited self reproducing and assumption of desired neuronal phenotype upon differentiation 
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(Isacson, 2003). The successful transplantation requires selective replacement of lost phenotypes 
and the re-establishment of the original connection patterns with local and distant host partners 
(Rossi and Cattaneo, 2002). 
Experimental transplantation studies for PD have been carried out during the last 30 years on 
rodents and non-human primates using a wide spectrum of cells including chromaffin cells 
(Freed et al., 1990; Unsicker, 1993), human neuroblastoma cells (Manaster et al., 1992), human 
amnion epithel cells (Kakishita et al., 2000). The best results, however, have been obtained only 
after transplantation of DAergic tissue derived from the ventral mesencephalon (VM) of different 
species into the striatum (for a review, Herman and Abrous, 1994). Studies have shown that 
grafted cells survived (Björklund et al., 1983), form synapses with host striatum (Björklund et al., 
1983; Mahalik et al., 1985; Doucet et al., 1989), are able to produce dopamine (Schmidt et al., 
1983; Triarhou et al., 1994,) leading to functional improvements in lesioned animals (Dunnett et 
al., 1983; Fisher and Gage, 1993). 
Since 1987, when the first clinical neural transplantation trials were initiated, some 350 
Parkinson's disease patients have received intrastriatal grafts of human fetal mesencephalic tissue 
(Lindvall and Björklund, 2004; Winkler et al., 2005). The outcomes of these studies demonstrate 
that transplanted human DAergic neurons survive and ameliorate many of the motor symptoms 
of advanced PD (Freeman et al., 1995a; Kordower et al., 1995; Defer et al., 1996; Hauser et al., 
1999; Piccini et al., 2000; Mendez et al., 2005).  
In animal models of HD transplanted fetal rat striatal cells have been demonstrated to survive, 
grow and reverse spontaneous motor abnormalities and at least partly normalize the metabolic 
hyperactivity in the extrapyramidal neural system (Deckel et al., 1983; Isacson et al., 1984; 
Campbell et al., 1993). Normal development of striatal grafts, connections with host brain and 
behavioural improvement in rodent models of HD have been described using human donor 
striatal grafts (Freeman et al., 1995b; Sanberg et al., 1997). In non-human primate models of HD, 
bradykinesia and dyskinesias induced by unilateral excitotoxic lesions of the striatum can be 
reversed by intrastriatal allografts of fetal striatal tissue (Kendall et al., 1998). Clinical trials have 
been performed on the basis of these experimental data. The transplantation of human fetal 
striatal tissue for the treatment of HD (Freeman et al., 2000) has shown that grafts can survive, 
develop and remain unaffected by the underlying disease process, at least for 18 months after 
transplantation in patients with HD, indicating no histological evidence of immune rejection. 
Despite these promising results, substitutive therapy in the treatment of neurodegenerative 
disorders like PD and HD, based on the intracerebral implantation of human fetal tissue appears, 
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at this time, to be hampered because of ethical and technical difficulties.  
Besides the ethical concerns related to the use of aborted human material, the viability and purity 
can also not be controlled. An additional obstacle for the use of fresh human tissue for 
transplantation is the poor survival of grafts. Only approximately 1 to 20% from grafted cells 
survives the transplantation procedure (Dunnett and Björklund, 1999). That means that 4-8 fetal 
brains are required for a significant reduction of symptoms in only one patient (Brundin et al., 
2000). Concerning both disorders, there are many technical and conceptual problems which are to 
be resolved before treatment approaches tested in the laboratory can be used in clinical trials.  
 
1.2 Stem and progenitor cells 
Stem cells biology has its own lexicon, often confused by uncertainty in definitions “stem” and 
“progenitor” and by establishing degree of “stemness”. Numerous reviews on stem cell biology 
have addressed the issue of a continuum of cell fate or differentiation from the most primitive 
precursor cells to the most differentiated adult somatic cell (reviewed by Steindler, 2007) for a 
complete list of definitions of stem and progenitor cells. To avoid misunderstandings while 
reading the thesis, here, the definitions and features of stem and progenitor cells will be given in 
brief. 
A stem cell is a cell from the embryo, fetus or adult, which has the ability for reproducing itself 
for long periods, or in the case of adult stem cells throughout the life of the organism.  The 
potency of a stem cell represents a range of cell types it can generate. Stem cells are the basic cell 
type from which all others emanate through restriction of potency. 
Totipotent is called the cell able to generate the entire organism. The fertilized egg is considered 
to be totipotent as it has the potential to give rise to virtually all cells. 
Embryonic stem (ES) cells are derived from the inner cell mass of the embryo in the blastocyst, 
one of the earliest stages (4-5 day) of development. They can in vitro replicate indefinitely. ES 
cells are pluripotent and have the potential to differentiate into all three germ layers of the 
mammalian body-the mesoderm, endoderm and ectoderm.  
Adult stem cells are undifferentiated cells that occur in a certain tissue. They are self-renewing 
and become specialized to yield all of the specialized cell types of the tissue from which they 
originated.  
Progenitor or precursor cells occur in fetal or adult tissues and are partially specialized. They are 
defined on the basis of two functional properties: limited capacity for self renewal and the ability 
to generate multiple mature neural cells. Stem and progenitor cells are distinguished in the 
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following way: a stem cell has the unlimited capacity to self renewal via symmetric or 
asymmetric division, whereas a progenitor cell has the ability to self-renew only for a limited 
period of time, before terminally differentiate into cells that are committed to a particular lineage. 
 
Tab 1: Basic features of stem and progenitor cells. 
Feature Stem cell Progenitor cell 
Self-renewal Unlimited Limited 
Plasticity Pluripotent Unipotent or multipotent 
 
Neural stem cells (NSCs) are cells of the nervous system (central as well as peripheral) that are 
self-renewing and multipotent. As the mammalian CNS develops, that is presumed that a gradual 
restriction occurs in the differentiation potential of NSCs. 
Neural progenitor cells (NPCs) present a population of cells with limited capacity for self 
renewal. They are a step further along than NSCs in the differentiation process; NPCs have 
committed to a particular lineage (neuronal or glial) and have begun to express lineage-specific 
markers. As the mammalian CNS develops, that is presumed that a gradual restriction occurs in 
the differentiation potential of neural stem and progenitor cells.  
Hence, NPCs has been defined as a relative undifferentiated population of cells that (i) are 
capable to generate the broad array of specialized neurons and glial cells in CNS, (ii) have limited 
capacity for self renewal, and (iii) can give rise to cells other than themselves through 
asymmetric cell division (Gage, 2000).  
1.3 In vitro expansion of neural progenitor cells 
ES cells clearly represent an interesting option for cell-based transplantation studies. While these 
cells can efficiently generate neurons “of interest” in vitro, after grafting they are affected with 
problems, including propensity of teratoma formation. The potential of mouse ES cells to 
generate functional DAergic neurons and to ameliorate behavioural deficits after grafting into 
parkinsonian rats has been demonstrated (Björklund et al., 2002). When low numbers of 
undifferentiated mouse ES cells were transplanted into the rat DA-depleted striatum, the cells 
differentiated into functional DAergic neurons, reducing parkinsonian symptoms. However, 
teratoma-like tumours were formed in 20% of animals at the implantation site. In an alternative 
approach, highly enriched populations of midbrain NPCs were developed in vitro from mouse ES 
cells and transplanted into parkinsonian rats (Kim et al., 2002). These cells survived 
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transplantation procedure, led to the recovery from Parkinsonism, and did not form teratoma 
tumors. The possibility to grow NPCs in laboratory unlimitedly and to induce their differentiation 
by providing them the factors required for full maturation make them an attractive cell source for 
cell-based therapies.  
It was previously suggested that in mammalian CNS progenitor cells were present only during 
development. However, neural progenitor cells have been isolated from various regions of the 
adult brain, including hypothalamus, dentate gyrus of the hippocampus and the forebrain 
structures subventricular zone (SVZ) and olfactory bulb (Temple and Alvarez-Buylla, 1999). In 
recent years, neurogenesis has been reported to occur in other regions of the adult brain such as 
the neocortex (Gould et al., 1999) and the SN (Zhao et al., 2003). More recently clonogenic 
NPCs have been isolated from mouse tegmentum and shown to express nestin and other NPCs 
markers. They formed spheres, differentiate in vitro in neurons, astrocytes and oligodendrocytes, 
had significant telomerase activity, displaying morphological and functional properties of mature 
neuronal subpopulations (Hermann et al., 2006). 
NPCs can be either directly extracted from fetal or adult nervous tissue and proliferate in culture 
(Cattaneo and McKay, 1990; Kilpatrick and Bartlett, 1993; Ling et al., 1998; Svendsen et al., 
1999; Vescovi et al., 1999; Akiyama et al., 2001; Arsenijevic et al., 2001), or embryonic stem 
cells can be extracted, proliferated and differentiated into neural precursor cells (Li et al., 1998; 
Brüstle et al., 1999; Lee et al., 2000; Schuldiner et al., 2001; Kim et al., 2007). NPCs can be 
isolated and propagated in vitro either by exposure of mitogens, or by producing immortalized 
cell lines. 
Epidermal growth factor (EGF) and fibroblast growth factor (FGF)-2 are factors most commonly 
used for in vitro propagation of NPCs. These factors have been found to stimulate the devision of 
embryonic and adult CNS progenitors (Kilpatrick and Bartlett, 1995). Cells isolated from the rat 
hippocampus in the presence of FGF-2 have been shown to express region-specific migration and 
neuronal differentiation after transplantation into the adult rat brain (Gage et al., 1995a; Suhonen 
et al., 1996). Embryonic mouse or rat forebrain progenitors expanded in the presence of EGF, by 
contrast, develop into predominantly glial phenotypes in vivo, as observed after transplantation 
into adult rat spinal cord (Hammang et al., 1997) or the developing rat forebrain (Winkler et al., 
1998). Cells, obtained from the embryonic (6,5-9 week of gestation) human forebrain and 
expanded in culture in the presence of EGF, FGF-2 and leukaemia inhibitory factor (LIF), have 
been shown to survive well after transplantation to both neurogenic and non-neurogenic sites, 
showing migration, integration and site-specific differentiation into both neurons and glia 
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(Fricker et al., 1999). NPCs obtained from a mixed brain fragment of a 22-week-old fetus and 
expanded in vitro in presence of EGF and FGF-2 have also demonstrated good survival and 
differentiation into neurons and astrocytes, responded appropriately to regional determinants after 
grafting in neonatal brain (Rosser et al., 2000).  
In the CNS, blockade of cell proliferation constitutes one of the events that are necessary for cells 
to undergo terminal differentiation. Likewise, they can be manipulated in vitro to stop 
proliferation to undergo terminal differentiation. This can be achieved by withdraw of mitogens 
(mitogen-expanded cells) or elevation of temperature (temperature-sensitive immortalized cell 
lines). These in vitro expanded cells can be used not only in transplantation experiments for the 
repair of CNS injuries and diseases, but also allow detailed study of the mechanism of neural 
proliferation, differentiation, and the role of different factors on cells phenotypic specialization 
(Schwartz et al., 2003). 
In vitro CNS-derived neural progenitors exhibit regionalization. Neurospheres generated from 
different CNS regions express region-appropriate markers and generate region-appropriate 
progeny: spinal cord-derived cells generate spinal cord progenitors (Mayer-Proschel et al. 1997), 
whereas forebrain-derived cells generated GABA-ergic neurons (Potter et al., 1999). 
Consistently, striatal progenitors derived into GABAergic neurons (Kallur et al., 2006), 
mesencephalic progenitors give rise into DAergic neurons, (Storch et al., 2001; Storch et al., 
2004; Miljan et al., 2008). The differentiation program can be influenced by exposure to various 
factors such as cytokines.  
Cytokines, a diverse group of polypeptides that are generally associated with inflammation, 
immune activation and cell differentiation or death, include interleukins (IL), interferons (IFN), 
tumour necrosis factors (TNF), chemokines and growth factors. Hematopoietic cytokines are a 
large group of proteins normally found in blood that are involved with clonal expansion and 
lineage restriction of stem and progenitor cells within the hematopoethic system. Many of these 
cytokines, including erithropoetin (EPO), colony stimulating factor (CSF), and several members 
of the IL-family, are found within the brain and have been shown to influence the development of 
neurons (Mehler et al., 1993). Another subclass of cytokines, growth factors, also plays an 
important role in regulating of NPCs proliferation and differentiation. While EGF, FGF-2 and 
transforming growth factor alpha (TGF) are mitogens for neural stem cells both in vivo and in 
vitro, other growth factors including bone morphogenic proteins (BMPs), platelet-derived growth 
factor (PDGF), ciliary neurotrophic factor (CNTF) and brain-derived neurotrophic factor (BDNF) 
can regulate stem cell differentiation. Chemically defined media, including cytokines, growth 
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factors and other substances supporting for cell differentiation, have been developed for obtaining 
desired cell phenotypes (Ling et al., 1998; Carvey et al., 2001; Yan et al., 2001; Le Belle et al., 
2004; Wang et al., 2004; Christophersen et al., 2006; Molina-Hernandez and Velasco, 2008).  
Another possibility for in vitro expansion offers the immortalization of cells. Immortalized cell 
lines are established by transduction of neural progenitors with a vector encoding an 
immortalizing oncogene. It has been shown that the immortalization process holds cells at 
particular stages of development and prevents their terminal differentiation (Ryder et al., 1990). 
Owing to the fact of immortalization cells remain in continuous cell cycle, multiply limitlessly 
providing large numbers for transplantation purposes. In addition they offer a possibility for 
genetic manipulations, which enables the production of growth factors and enzymes.  
Many immortalized cell lines seem to share in vitro properties with primary progenitors, for 
example, they express nestin and can express cell adhesion molecules (reviewed by Snyder, 
1994).  
For the production of immortalized cell lines, cells are transfected with oncogenes of different 
isoforms of myc, neu, p3, adenoviral E1A and SV large T antigen. V-myc propagated NPC lines 
include C17.2, derived from mouse cerebellum (Ryder et al., 1990), H6, derived from human 15-
week-old telencephalon (Flax et al., 1998), HNSC.100, derived from human 10-week-old 
forebrain (Villa et al., 2002), Mes2, derived from human 8-week-old VM (Lotharius et al., 2002). 
Such cells response to EGF and FGF-2: they proliferate in response to EGF and FGF-2 and after 
removal of growth factors undergo terminal differentiation. A clonal NPC line from human fetal 
cortical tissue was established via immortalization with v-myc (Cacci et al., 2007). The cells 
showed a high proliferative ability in the presence of EGF and FGF-2. When growth factors were 
withdrawn, proliferation and expression of v-myc and telomerase were dramatically reduced, and 
the NPCs differentiated into glia and neurons (mostly glutamatergic and GABAergic as well as 
DAergic). NPCs derived from VM of 10-week old embryos and immortalized with the c-
mycERTAM transgene have shown after removal of growth factors EGF and FGF-2 differentiation 
into neurons, astrocytes and oligodendrocytes; the cells were able to generate TH-positive 
neurons demonstrating that even though they are multipotent, they still displayed some brain 
region restricted differentiation (Miljan et al., 2008). 
Other authors immortalized neural cells with the temperature-sensitive mutant of the SV40 Large 
T antigen establishing stable homogenous cell populations in vitro: cells, derived from 
developing rat cerebellum (Frederiksen et al., 1988), CSM14.1 cells derived from VM region of 
E14 rat (Zhong et al., 1993), ST14A cells derived from striatum of E14 rat (Cattaneo et al., 
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1994). The cell lines immortalized with SV40 are useful for preclinical transplantation studies, 
because they proliferate in culture at a permissive temperature of 33° C, and begin the 
differentiation after elevation of the temperature to the nonpermissive 39° C, which is in 
correspondence with the temperature of the rodent brain, allowing them to stop proliferation and 
differentiate after transplantation. 
Immortalized cell lines can be induced in vitro to produce certain neuronal phenotypes. By an 
effective in vitro protocol a homogenous population of functional GABAergic neurons were 
obtained from rat striatal line ST14A (Bosch et al., 2004). These cells survived transplantation 
into the adult rat brain and maintained their acquired fate in vivo. 
The propensity of immortal non-transformed rat mesencephalic cell line AF5 to differentiate in 
response to high confluence culture condition and serum starvation to exhibit GABAergic 
lineage-specific properties has been also demonstrated (Sanchez et al., 2006).  
Immortalized cell lines have shown capacity to differentiate into several neuronal cell types when 
transplanted (Martinez-Serrano and Björklund, 1997). The transplantation of immortalized cells 
into the neonatal brain resulted in a differentiation into neurons and glia with apparent region-
specific morphology (Renfranz et al., 1991; Snyder et al., 1992; Cattaneo et al., 1994). When 
transplanted into the adult rat striatum, immortalized cells generated from embryonic 
hippocampus or striatum, usually form glia (Lundberg et al., 1997). Cells derived from 
embryonic rat VM and immortalized with SV-40 have been detected to form tyrosine 
hydroxylase (TH)-ir neurons after grafting, improving motor behaviour in parkinsonian rats 
(Haas et al., 2007).  
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Chapter 2: General results and discussion 
2.1 In vitro characterization of the striatal neuronal precursor cell line ST14A 
The use of neural stem cells for transplantation is a rapidly expanding field.  
An important source for cell transplantation purposes present immortalized cell lines (Frederiksen 
et al., 1988; Whittemore and Onifer, 2000). Immortalized cells can undergo limitless numbers of 
divisions and are often resistant to apoptosis (Hahn and Meyerson, 2001). Thus, such cells 
provide a supply for unlimited numbers of homogenous and stable cells for research, allowed 
controlled genetic modifications and are highly suited for the extensive characterization and 
validation of data needed for their clinical use. 
The most commonly used oncogens for immortalizing cells are members of the myc oncogene 
family or a temperature sensitive mutant of SV40 large T antigen (Gage et al., 1995b). In neural 
cell lines developed by constitutively expressing oncogenes such as myc, the mitotic activity of 
oncogene is always present, and cells proliferate continuously in culture. Differentiation of the 
immortalized progenitor cells into neurons may require sufficient down-regulation of the 
oncogene, but attempts to induce terminal differentiation often induce apoptosis (Rubin et al., 
1993). Additional factors are required to achieve terminal differentiation of neural cell lines 
immortalized with myc. To obtain a regulatable expression of the immortalizing oncogene, a 
temperature sensitive mutant of SV40 large T antigen (tsA58) has been used for the conditional 
immortalization (Mehler et al., 1993). 
In the Publication 1 in vitro properties of immortalized cell line ST14A cells have been 
investigated to evaluate their potential for experimental studies. Embryonic striatal conditionally 
immortalized ST14A cell line was established via retroviral transduction of the temperature-
sensitive mutant of the SV40 Large T antigen (ts A58/U19 allele) into primary cells derived from 
embryonic day 14 primordial rat striatum. Like their immature progenitors from which they 
where derived, ST14A cells maintained the expression of nestin at a permissive temperature of 
33° C and exhibited a response to FGF-2 stimulation (Cattaneo and Conti, 1998). Upon shifting 
to the nonpermissive temperature of 39° C, the expression of the Large T antigen was down 
regulated, as has also been shown by experiments conducted in other immortalized cells 
(Renfranz et al., 1991). In the same study ST14A cells have been shown to express microtubule 
associated protein 2 (MAP2), messenger RNAs of various neutrophins (NGF, NT3, BDNF, 
bFGF, CNTF; shown by RNase protection assay) and produce neutrophin receptors (TrkA, TrkB, 
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TrkC, p75NGFR shown by Western blotting or RT-PCR). 
Here, we investigated in vitro properties of ST14A cells for up to 14 days. As expected from 
previous studies, cells proliferated extensively producing neural progenitor cell markers nestin 
and vimentin at the permissive temperature in serum containing medium. The cells also 
continued to multiply their number at nonpermissive temperature, but the proliferation was 
drastically slowed down. In the serum-free medium at 39 C almost the same number of cells was 
found at days 0 and 14, indicating the entire stop of proliferation. It was concluded, that only the 
elevation of the temperature is not enough for stop of proliferation.  
The expression of NPCs markers nestin and vimentin was drastically decreased after shifting the 
temperature to 39 C. Low levels of both markers, however, were weakly detectable even after 14 
days of culture at the nonpermissive temperature, indicating that cells partially (or at least some 
of them) maintained the expression of progenitor markers. 
Concerning differentiation, neuronal markers appearing earlier in the neural development such as 
(neuronal specific enolase) NSE, NF160 (neurofilament 160), NF200 (neurofilament 200) and 
microtubule associated protein 5 (MAP5) were weakly detectable already at permissive 
temperature. Similar observations have been made by Ehrlich et al. (2001), suggesting that even 
in the immortalized state, ST14A cells are expressing antigens characteristic of neurons which 
have progressed beyond the progenitor state. The expression of these markers increased after 
shifting of the temperature to 39 C. Even at 39 C neuronal markers NeuN (neuronal nuclei) and 
MAP2, typical for mature neurons have been never observed. In another study MAP2 (Cattaneo 
and Conti, 1998) has been detected by Western-blot analysis. Here, it can be speculated, that 
mature neuronal markers are expressing yet only at low levels, making them undetectable for 
immunocytochemistry.  
The phenotypic range of a precursor that is immortalized depends on the potential of the 
precursors normally prevalent in a given region at the given developmental stage. By an effective 
culture condition including factors supporting for neural differentiation ST14A cells have been 
shown to differentiate into GABAergic neurons in vitro (Bosch et al., 2004).  
The temperature-sensitive variant of SV40 large T antigen has been the main choice for the 
conditional immortalization. However, many studies failed to demonstrate full differentiation of 
the immortalized cells by only switching the temperature from the permissive to the 
nonpermissive one (Frederiksen et al., 1988; Mehler et al., 1993). It can be concluded, that 
additionally factors like growth factors and cytokines and appropriate substrates are needed in 
addition to elevation the temperature to provoke complete differentiation of immortalized 
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precursor cells. 
 
2.2. In vitro characterization of mesencephalic hNPCs 
Neural transplantation using tissue from the fetal human CNS offers a possible therapeutic 
approach for treatment of PD (Lindvall, 1994). However, a wide application of this therapy is 
hindered. One factor limiting the widespread application of neural cell transplantation as a 
treatment for neurodegenerative diseases is the lack of availability of suitable donor tissue for 
transplantation. In vitro propagation of NPCs enables to study their intrinsic properties more 
detailed and to obtain large numbers of cells for transplantation studies.  
The success in treating neurodegenerative animal models of PD (Nishino et al., 2000) with rodent 
NPCs, has prompted efforts to develop and produce human NPCs (hNPCs) with regard to their 
DAergic differentiation. Midbrain DAergic neurons are generated from the precursor cells in the 
ventricular zone (VZ) of the developing VM. After mitosis in the VZ, the precursor cells migrate, 
start expressing specific markers including TH, and differentiate into mature DAergic neurons 
(Kawano et al., 1995). Many laboratories have investigated the potential of growth factors 
expanded neural progenitors to integrate and restore function in animal models of 
neurodegenerative diseases. Under optimal conditions mesencephalic progenitors have been 
reported to yield neurons in which 24% are DAergic (Studer et al., 1998). Attempts have been 
made to enhance DAergic differentiation: Ling et al. (1998), reported, that mesencephalic 
progenitor cells derived from fetal rat brain could give rise to DAergic neurons using a 
combination of interleukin-1 (IL-1), IL-11, LIF and GDNF. In the culture of rat mesencephalic 
progenitor cells the DAergic differentiation was increased after treatment with ascorbic acid (Yan 
et al., 2001). 
For clinical treatment of different types of neurodegenerative diseases, however, an important but 
yet unfulfilled goal is the generation of large numbers of neurons from expanded human cultures, 
which possesses more advantages than those from animals. The successful conversion of rodent 
NPCs to DAergic neurons has prompted intensive efforts to develop hNPCs with the view to 
their differentiation into DAergic neurons. 
NPCs obtained from the human first semester forebrain were expanded in vitro as free-floating 
neurospheres, and their TH-differentiation was induced by factors including acidic FGF, 
combined with factors that activate protein kinase C (Christophersen et al., 2006). 
In the present study (Publication 2 and Publication 3) cells from the VM of a human embryo of 8 
weeks of gestation have been used. Mesencephalic precursor cells derived from the VM of 
 17
developing brain appear to be a good candidate cell source for DAergic precursors. These cells 
have transcription factors characteristic of their midbrain origin, and can respond to 
environmental signals by rapidly differentiation into DAergic neurons. The DA character of VM-
derived cells has made them an attractive candidate source for donor cells that can be used in 
cell-based therapy for PD. The twofold purpose of this study was the (i) characterization of 
mesencephalic hNPCs in vitro and (ii) obtaining sufficient numbers of cells for transplantation 
experiments.  
We expanded the cells in the medium containing EGF and FGF-2 for up to 6 months. 
Long term neurosphere cultures have been generated using this combination (Vescovi et al., 
1993). Nestin and vimentin are markers which are predominantly expressed in proliferating 
NPCs. A high percentage of NPCs isolated from human embryonic VM (7-8 weeks) has shown 
immunoreactvity for vimentin (Riaz et al., 2002). Here, we show that hNPCs from VM of 8-
weeks old embryo proliferate continuously in the presence of EGF and FGF-2, expressing nestin 
and vimentin. The expression of nestin and vimentin in undifferentiated hNPCs is consistent with 
the presence of these intermediate filament proteins in stem and progenitor cells in the 
mammalian CNS (Lendahl et al., 1990). 
To induce cell differentiation they were allowed to form spheres, in serum-free medium without 
human EGF and FGF-2, which were then plated on poly-L-lysin/laminin-1-coated glass cover 
slips for adherence. In principle, the in vitro differentiation of neurosphere-forming cells includes 
five steps: stop of proliferation, attachment of the neuroshpere to the surface of cell culture 
dishes, detachment of cells from the neurosphere, migration of these cells away from the sphere 
and their differentiation into different cell types in response to environment.  
24 hours after plating the immunocytochemical analysis was performed. We have shown here, 
that these cells, expanded as neurospheres, are positive for microtubule associated protein 5 
(MAP5). MAP5 is essential for the growth and elongation of neuronal processes and is expressed 
earlier than all other MAPs. It is suggested that phosphorylated MAP5 is expressed in developing 
axons, decreases with maturation and remains as its non- phosphorylated form in cell bodies and 
dendrites at adulthood (Ohyu et al., 1997).  
Some of these MAP5 positive cells were also expressing TH. As TH is the rate limiting enzyme 
involved in the synthesis of catecholaminergic neurotransmitters, these neurons co-expressing 
MAP5 and TH and exhibiting traditional DA neuron morphology with long processes, were 
considered to be of DAergic phenotype. 
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2.3. In vivo characterization of in vitro expanded hNPCs, transplanted into the lesioned rat 
brain 
In vitro culture systems permit testing the cellular properties of isolated cell lines and their 
behaviour under different conditions and factors affecting the fate of expanded cells. In the next 
step, however, it is very important to test these cells in vivo. After intracerebral stereotactic 
transplantation the differentiation of cells can differ noticeably compared to the in vitro 
conditions.  
Here, we generate an animal model of PD to investigate the behaviour and functional effects of in 
vitro expanded hNPCs after grafting into lesioned neonatal and adult striatum. To investigate the 
characteristics of hNPCs after grafting and to address how factors in their environment might 
influence their survival, differentiation and migration, we transplanted in vitro expanded hNPCs 
both into developing and adult rat brain 
Animal models of PD allow researchers to study the pathology of PD while mimicking physical 
and behavioural changes during the entire disease course. Animal models of PD are a useful tool 
not only for understanding the pathology of this disorder, but also for the preclinical trials, 
including cell replacement therapy. In the present study (Publication 2 and Publication 3) animals 
were unilaterally lesioned with 6-hydroxydopamine (6-OHDA). 
The 6-OHDA rat lesion model is the most extensively used animal model for PD, because it 
reflects many symptoms of the disorder and give rise to a reliable and typical lesion pattern 
(Cenci, 2002). 6-OHDA is a neurotoxin that selectively destroys catecholaminergic neurons and 
it is typically injected unilaterally, since bilateral injections cause high mortality in adult animals 
(Iancu et al., 2005). Cytotoxity of 6-OHDA is due to its pro-oxidant activity: the toxin undergoes 
rapid auto-oxidation in the extracellular space promoting a high rate of reactive oxygen species 
formation which is associated with activation of the apoptotic cascade (Blandini et al., 2007). 
Intracerebral injection of 6-OHDA into the rat nigrostriatal pathway has been shown to 
permanently degenerate virtually all DAergic neurons in the SN pars compacta (Javoy et al., 
1976; Jeon et al., 1995) leading to stable motor deficits over the time. The toxin can also be 
injected intrastriatally or directly into the SN. The advantage using unilateral 6-OHDA lesioned 
model is to afford a more easy assessment of motor impairments by utilizing tests that examine 
for a side bias- and drug-induced rotation (Ungerstedt and Arbuthnott, 1970).  
In an animal model of PD, bilateral nigrostriatal lesions in rats (typically made by central 
injection of the toxin 6-OHDA into the medial forebrain bundle (MFB)) induce akinesia, rigidity, 
and catalepsy, whereas unilateral lesions produce deficits in tests of lateralised function, 
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including rotation in response to DAergic drugs, impairments in use of contralateral limb and 
increased grip strength with the contralateral paw (Jeyasingham et al., 2001). In the present study 
(Publications 2 and Publication 3) we have explicitly compared lesioned only rats with those 
transplanted with hNPCs after lesion and sham transplanted ones using two tests of locomotor 
lateralisation of motor functions i.e. apomorphine-induced rotation test and the cylinder test.  
Both tests allow not only to characterize the extent of lesion but also to detect therapeutical 
effects of mesencephalic grafts.  
It is generally accepted that xenografts (between animals of different species) and allografts 
(between outbred individuals of the same species) typically show rapid rejection occurring in a 
matter of days in non immunoprivileged organs like the liver or the kidney. 
Cyclosporin A (Cy A) is a potent immunosuppressive drug widely used in clinical transplantation 
to prevent graft rejection. Cy A has been found in prolonging survival of a variety of xenografts 
transplanted to rat brain (Lund et al., 1987). However Cy A has been reported to enhance 
DAergic function (Borlongan et al., 1995) and, therefore, could theoretically contribute to the 
clinical benefit by xenotransplantation. The use of Cy A is complicated because the long-term 
costs and task of justifying the symptomatic relief. 
In our study neither neonatal nor adult animals have been immunosuppressed. The brain is 
considered to be an immune-privileged site, which permits xenotransplantaton of the graft 
without the requirement for immunosuppression (Carson et al., 2006; Galea et al., 2007). Many 
explanations of immunologic privilege of CNS have been offered, including blood-brain barrier 
that prevents the access by the immune system to the site of injection. We have not found any 
evidence of immune response, using immunohistochemistry against OX-42. All cells positive for 
OX-42 exhibited morphology typical for the resting stage, concluding that microglia was not 
activated. In a nonimmunosuppressed adult rat the host immune response to a xenotransplant into 
the brain is typically initiated within 2 days following grafting and the complete destruction of 
the xenotransplant occurs within 30 days of transplantation. Human retinal pigment epithelial 
cells, transplanted into lesioned adult rat striatum survived 18 weeks without immunosuppression 
and showed no detectable evidence of a graft versus host immune reaction (Subramanian et al., 
2002). 
In the present work human cells have been shown to survive in the rodent environment without 
immunosuppression. It has been already shown that EGF-responsible human progenitor cells 
grown for 3 weeks in vitro can survive transplantation procedure into the lesioned rat striatum, 
but after 4 weeks postgrafting the transplants appeared very diffuse with only few scattered 
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DAergic neurons (Svendsen et al., 1996). Likewise, FGF-2-responsive human progenitors 
survive transplantation into adult rat striatum when grafted at very high density, although, again, 
the survival time has been assessed only 2-3 weeks (Sabate et al., 1995). Here, we show, that 
when expanded in vitro in presence of both factors, hNPCs survive at least 12 weeks after 
transplantation into adult hemiparkinsonian rat striatum.  
Nevertheless, it should be pointed out that the survival was much better in the neonatal striatum 
than in the adult. The reasons for the poor survival of transplanted cells are yet to be clarified. It 
seems likely that poor cell survival owes to many factors such as mismatch conditions, lack of 
supporting trophic factors, free radical-mediated toxity and apoptosis. Not only survival, but also 
migration and differentiation were delayed in the adult hemiparkinsonian animals, confirming the 
view that specific, time-dependent patterns of promoting and inhibiting factors of the 
extracellular matrix and neural receptors of neonatal and adult striatum differ. In neonates some 
of the grafted hNPCs migrated up to 2000 μm to the subependymal region of lateral ventricle or 
along the corpus callosum, while in the adult environment only a small minority of cells 
exhibited migration to the surrounding parenchyma (600 μm). 
Here, we performed heterotopic transplantation, grafting hNPCs derived from mesencephalon 
into the striatum. Although the reinnervation of other DA-denervated basal ganglia such as the 
SN and subthalamic nucleus may also be important, optimal placement of the graft within the 
striatum may be necessary to maximize the functional recovery (Baker et al., 2002).  
Concerning TH-expression, and therefore a putative DAergic differentiation, the neonatal and 
adult environments also differed strongly. In neonates a small number of TH-ir cells were 
detected. Nevertheless, adult ones lacked DA-ergic differentiation, suggesting one more time that 
the adult striatum is not able to support DAergic differentiation. 
Other studies speak in support of this proposal: neural mesencephalic progenitor cells of the 
immortalized cell line CSM 14.1 did not differentiate in TH positive neurons after transplantation 
into the adult striatum (Anton et al., 1995), whereas the transplantation of the same cells into the 
neonatal dopamine-depleted striatum resulted in a DAergic differentiation, followed by motor 
behaviour improvement (Haas et al., 2007). 
A recent study on rodent neural progenitor cells (13.5 day of gestation) has shown that grafted 
VM cells developed to TH-expressing mature neurons strongly at 3 weeks, peaked at 4 weeks, 
following by the decrease of TH-expression at 5 and 6 weeks postgrafting (Park et al., 2007). In 
neonate animals 5 weeks after transplantation TH-ir cells were detected. Immunohistochemical 
analysis in adults was only performed once (12 weeks postgrafting), and it can be also speculated 
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that by this time TH differentiation has been gradually reduced.  
Although non-expanded precursors transplanted into developing brain have shown extraordinary 
plasticity in neuronal differentiation (Vicario-Abejon, 1995), in vitro expanded cells have much 
lower success in generation of neurons especially when grafted into adult environment. The 
transplantation of in vitro expanded human mesencephalic progenitors did not result in sufficient 
differentiation of DAergic neurons to completely resolve the behavioural defects in an animal 
model of PD (Svendsen et al., 1996; Svendsen et al., 1997). Rat mesencephalic NPCs expanded 
in the presence of FGF-2 have been also clearly shown to lose the efficiency of DAergic 
differentiation after long-term expansion and passaging (Yan et al., 2001). 
It is notable that in our studies the vast majority of survived cells underwent neuronal 
differentiation and was immunopositive for the neuronal marker NeuN in both neonates and 
adults, suggesting that hNPCs can undergo neurogenesis even in the lesioned non-neurogenic 
environment of the adult striatum and assume a neuronal phenotype. This is in agreement with a 
work showing marked neural differentiation following grafting of cortical NPCs into DA-
depleted striatum but no TH expression, whereas the same cells were able to express TH in vitro 
(Yang et al., 2002). It is unknown why in vitro expansion of cells might result in a loss of their 
potential to differentiate into DAergic neurons after transplantation. It can be proposed that under 
conditions used for cell expansion in vitro cells altered and lost their identity as DAergic 
precursors. Endogenous precursor cells have access to spatiotemporal information and 
environmental molecular signalling that is important for adopting a specific fate. Long-term 
culture under stimulation with growth factors causes the loss of such information for unknown 
reasons, which are to be clarified (Santa-Olalla et al., 2000). 
In experimental animals there is a documented correlation between the numbers of surviving 
DAergic neurons in grafts and the degree of restoration of behavioural deficiencies due to lesions 
of the nigrostriatal pathway (Wang et al., 2004). In motor behaviour tests demonstrated neonatal 
animals a marked improvement of impaired motor functions. It should been pointed, that only a 
sparse TH-differentiation of grafted cells was observed. It seems unlikely, that a robust 
behavioural effect is caused by only rare TH-ir cells. Moreover, no TH-differentiation was 
observed in cells, grafted into the adult striatum. A behavioural improvement, however, has been 
also observed. Similar results have been recently obtained by Miljan and colleagues (Miljan et 
al., 2008). Implantation of the undifferentiated human mesencephalic immortalized NPCs into the 
striatum and SN of 6-OHDA unilaterally lesioned rats, displayed sustained improvements in a 
number of behavioural tests, whereas histological analysis shown no evidence of differentiation 
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into TH-positive neurons. 
It is obvious to speculate, that not only DA produced by grafted cells is contributed to motor 
behavioural improvement of lesioned animals, but also further factors are responsible for these 
effects. hNPCs, transplanted both in neonatal as well as in adult hemiparkinsonian rats, 
differentiated not only in neurons but also in astrocytes, as shown by immunohistochemistry for 
the astroglial marker glial fibrilary acidic protein (GFAP). This may indicate some important 
roles played by these exogenous astrocytes in improving local striatal environments and thus the 
overall behavioural improvement after transplantation. It has been shown that intrastriatal 
administration of GDNF in 6-OHDA lesioned rats exhibits functional recovery as well as 
supports the regeneration of the nigrostriatal dopaminergic circuitry (Gash et al., 1996). It can be 
supposed, that GDNF, expressed by astrocytes is at least partially contributed to the alleviation of 
PD symptoms. Alternatively, grafted cells could give rise to another type of neurons, for example 
GABAergic, which could lead to perturbations in other neurotransmitter systems, contributing 
partially to the behavioural recovery (Winkler et al., 1999). The fact remains that unknown 
factors are responsible for the improvement in motor behaviour. Further investigations are 
required to determine the nature of these factors. 
The usefulness of NPCs transplantation in PD treatment is now well-accepted. However, results 
from either rodent or primate animal models remain inconsistent. Before human progenitor cells 
transplantation becomes a routine method for the treatment of patients with PD, many related 
problems are to be resolved. On the present basis of results obtained till now in animals and 
humans, it is possible to identify a set a requirements that need to be fulfilled by neural 
progenitor cells to induce marked clinical improvement: firstly, the cells should release DA in a 
regulated manner and show the molecular, morphological and electrophysiological properties 
characteristic for midbrain neurons. Secondly, the cells must be able to reverse in animals those 
motor deficits that resemble the symptoms in persons with PD. Finally, the grafts must become 
functionally integrated into host neural circuitries.  
The results presented here are promising in the line of survival, differentiation and migration of 
hNPCs following grafting into the striatum of lesioned animals. We show, that even in the 
absence of immunosuppression, human cells survive, and moreover, are able to marked 
differentiation into neurons and glia. In the future, attempts will be made to improve their 
survival and enhance the fate of TH-differentiation. 
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2ABSTRACT 
The embryonic striatal temperature sensitive immortalized ST14A-cell line was characterized 
in vitro by immunocytochemistry when cultured at 33°C and at nonpermissive temperature of 
39°C for up to 14 days. At 33°C in DMEM/10% FCS, cells proliferated, were extensively 
expressing the neural progenitor cell markers nestin and vimentin contrary to neuronal 
markers. However, when cultured at 39°C the proliferation was delayed and cells began to 
increase the expression of neuronal markers, followed by a decrease of nestin and vimentin. 
In serum-free medium the process of neuronal differentiation became more obvious, 
indicating the potential to use these cells for experimental restorative therapies. 
3Abbreviations 
BSA, bovine serum albumin
CNS, central nervous system 
DMEM, Dulbecco’s modified Eagle’s medium  
FCS, fetal calf serum 
MAP2, microtubule associated protein 2 
MAP5, microtubule associated protein 5 
NF160, neurofilament 160 
NF200, neurofilament 200 
NeuN, neuron-specific nuclear protein 
4INTRODUCTION
Cell replacement therapy for the treatment of central nervous system (CNS) disorders has 
recently become widespread (Lindvall & Kokaia, 2006). The cells for transplantation 
purposes should fulfil a number of requirements including unlimited availability, long-term 
stability in vitro as well as in vivo and suitability for genetic manipulations.  
The immortalization of cell lines allows yielding a large number of appropriate cells in 
homogeneity (Cattaneo et al., 1994; Englund et al., 2002; Thompson, 2005; Xu et al., 2004).
Conditionally immortalized neuronal progenitor cells are interesting candidates for cell 
transplantation in experimental neurodegenerative processes, as the nonpermissive 
temperature for the immortalizing oncoprotein corresponds to the brain temperature of 
rodents (Björklund, 1993; Gage et al., 1991; Martinez-Serrano & Björklund, 1997; McKay, 
1992). The most commonly used oncogens for immortalizing cells are members of the myc 
oncogene family or a temperature sensitive mutant of SV40 large T antigen (Gage et al., 
1995).
The embryonic striatal conditionally immortalized ST14A-cell line, established via retroviral 
transduction of the temperature-sensitive mutant of the SV40 Large T antigen (ts A58/U19 
allele) into primary cells derived from embryonic day 14 rat striatum primordia, has the 
ability of self renew und to give rise to various terminally differentiated cell types (Cattaneo 
& Conti 1998). At the permissive temperature of 33°C ST14A-cells proliferate over extended 
periods of time and express the immortalizing oncoprotein and the intermediate filament 
protein nestin, whereas at the nonpermissive temperature of 39°C the immortalizing 
oncoprotein is down regulated, the proliferation is reduced followed by a decrease of 
expression of nestin and the differentiation into neuronal cells. This cell line was chosen from 
among many clones because of high proliferative ability (Cattaneo & Conti, 1998). 
ST14A-cells present a homogenous, stable and highly transfectable cell line, providing an 
opportune source for gene manipulations to express particular genes of interest (Böttcher et 
al., 2003; Corti et al., 1996; Pahnke et al., 2004; Weinelt et al., 2003). 
Most recently ST14A-cells and their transfectants were used as a cellular model for the 
investigation of the role of different factors in cell development (Bajorat et al., 2005), 
proliferation and motility (Cacci et al., 2003), differentiation (Peters et al., 2004), migration 
(Gambarotta et al., 2004) and death (Wang et al., 2001). 
ST14A-cells, transduced retrovirally to express a factor for regression of glioma tumors 
(Barresi et al., 2003; Benedetti et al., 2000), had a strong reducing effect on glioma cells. 
5Moreover, native ST-14A cells were shown to have the ability to inhibit tumour outgrowth 
when implanted into rats, those indicating the usefulness for the treatment of intracranial 
tumours (Staflin et al., 2004). 
Under certain culture conditions the ST14A-cells display several characteristics specific to 
striatal medium-size spiny neurons, albeit immature ones (Ehrlich et al., 2001). 
When transplanted into embryonic rat brain, ST14A cells aggregate into clusters and migrate 
while changing both their antigenic properties and ability to proliferate (Cattaneo et al., 1994). 
Following intracerebral grafting procedure into the adult striatum, ST14A cells survive 
without forming tumors, differentiate preferentially into mature glial cells, including 
astrocytes, oligodendrocytes and pericytes, fully integrated with the resident glial population 
(Lundberg et al., 1996).
In the light of increasing interest towards ST14A cells as putative candidates for preclinical 
approaches in animal models, here, to define the potential and limits of these cells, we 
investigated their proliferation and differentiation capacities under different culture conditions 
for up to 14 days in vitro. 
MATHERIAL AND METHODS  
Cell culture  
ST14A-cells were routinely grown in petri-dishes in 5% CO2/95% air in a humidified 
incubator at 33°C and were fed with Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal calf serum (FCS, Gibco). After expansion the cells were 
resuspended by trypsinization and collected by centrifugation (10 min, 600 rpm). Single cell 
suspensions were prepared (DMEM+10% FCS), the final cell density being about 2x105
cells/ml. For further analysis of cell differentiation under various culture conditions 
(temperature, medium, time) cell suspensions were transferred to poly-D-lysine coated 
culture-slides (8 chamber slides, Becton Dickinson), 5 μl of cell suspension to each chamber, 
i.e. about 1000 to 1500 cells per 0,69 cm2. Cells were allowed to adhere for 12 h (33°C, 
DMEM+10% FCS), thereafter changes of temperature and media were initiated. Cells were 
further cultured (i) in DMEM+10% FCS at 33°C for 3 days, (ii) in DMEM+10% FCS at 39°C 
for 3, 7 and 14 days, (iii) in serum free medium (Start V-medium, Biochrom) at 33°C for 3 
days and (iv) at 39°C for 3, 7 and 14 days. Media were supplemented with 100 U/ml 
penicillin and 100 μg/ml streptomycin (Gibco) and changed every third day.  
6Immunocytochemistry 
Prior to immunofluorescence analysis cells were washed with 0.9% sodium chloride, fixed 
with 4% paraformaldehyde in 0.1 M PBS (pH 7.4) at 4°C for 15 min, rinsed in 0.1 M Tris 
buffer (pH 7.4; 3 x 10 min) and preincubated in 0.1 M Tris buffer (pH 7.4) containing 3% 
bovine serum albumin (BSA) (Sigma), 3% normal goat serum (Gibco) and 0.05% Triton for 
1h. Thereafter, cells were incubated with the primary antibodies, diluted in 0.1 M Tris buffer 
(pH 7.4) containing 1% BSA and 0.025% Triton over night at 4°C, against nestin (1:4, 
supernatant, diluted in Dulbecco´s phosphate buffered saline, monoclonal antibody rat 401 
anti nestin, kind gift from R. McKay), vimentin (1:200, mouse monoclonal, Sigma), neuron 
specific enolase (NSE, 1:1000, rabbit polyclonal, Chemicon), microtubule associated protein 
2 and 5 (MAP2, 1:500, mouse monoclonal Sigma; MAP5, 1:500, mouse monoclonal, Sigma), 
neurofilament 200 (NF200, 1:100, rabbit polyclonal, Sigma), neurofilament 160 (NF160, 
1:50, mouse monoclonal, Sigma) and neuron-specific nuclear protein (NeuN, 1:1000, mouse 
monoclonal, Chemicon). Then the cell preparations were washed 3 x 10 min in 0.1 M Tris 
buffer and further incubated overnight at 4°C with polyclonal secondary anti-mouse (FITC-
conjugated, 1:100, Chemicon) or anti-rabbit (Cy3-conjugated, 1:500, Dianova) antibodies. 
Finally, specimen were again washed for 10 min in 0.1 M Tris buffer, and cell nuclei were 
stained for 5 min with 0.03% (w/v) with 4´,6-diamidino-2-phenylindole (DAPI) in 0.1 M Tris 
buffer at room temperature, again washed 2 x 10 min in 0.1 M Tris buffer followed by 
destilled water, and mounted in anti-fading fluorescence mounting medium. Controls 
consisted of omission of primary antisera. They exhibited non-specific background 
fluorescence. 
Analysis
Cell cultures were analyzed for the intensity of labelling with the various antibodies with a 
fluorescence microscope (Leitz Aristoplan, Wetzlar, Germany) using the respective filter 
units. Relative intensity of immunostaining was judged by the observer and scaled as - (not 
detectable), or if positive as + (sparse or weak), ++ (moderate) or +++ (extensive or strong). 
Cell growth was monitored at different time points under different culture conditions by 
counting the cell nuclei after nuclear staining with DAPI, the numbers of at least twelve 
chambers being expressed as mean ± SD per well.  
7RESULTS
In serum containing medium at 33°C cells rapidly proliferated increasing the number per 
chamber from 1206 ± 500 to 6514 ± 2734 in 3 days, whereas at 39°C respective numbers 
(9013 ± 3016) were reached after cultering for 14 days (Fig. 1a). However, culture in serum 
free medium at 39°C stopped cell devision so that comparable cell counts were found at day 0 
(1464 ± 546) and at day 14 (1421 ± 455) (Fig. 1b). 
Cultured at the permissive temperature in DMEM+10% FCS medium ST14A-cells grow in a 
monolayer and retained a flat, polygonal fibroblast-like morphology with stunted processes. 
Cells were extensively immunostained against nestin (Fig. 2a) and vimentin (Fig. 2f), 
moderate against NSE, NF200 and NF160, sparse against MAP5 (Fig. 2c), but were 
immunocytochemically negative for MAP2 and NeuN. In the DAPI staining mitotic figures 
were often seen (not shown). When cultured at the nonpermissive temperature of 39°C in 
DMEM+10% FCS medium ST14A-cell growth slowly proceeded (Cattaneo & Conti, 1998) 
up to 14 days, the cells retained their flat morphology developing short processes only. 
Depending on culture time at the nonpermissive temperature (3 to 14 days), immunostaining 
changed speaking in favour of a neuronal differentiation. Immunostaining against both nestin 
(Fig. 2b) and vimentin (Fig. 2g) drastically decreased but was still sparsely detectable after 14 
days, however, that against the neuronal markers NSE, NF200, NF160 and MAP5 increased 
over time, most obviously seen for MAP5 (Fig. 2d). Even at 14 days at the nonpermissive 
temperature, ST14A-cells were immunocytochemically negative for MAP2 and NeuN. In the 
DAPI staining a decreasing number of mitotic figures were seen with increasing culture time. 
After 3 days of culture in serum free medium (Start-V-medium) at 33°C ST14A-cells were 
moderately immunostained against nestin and only sparsely against vimentin, extensively 
against NF200 and NF160, and sparsely against MAP5, NSE. In the DAPI staining mitotic 
figures were also seen. Depending on culture time at the nonpermissive temperature (3 to 14 
days) in serum free medium, immunostaining drastically changed towards neuronal 
differentiation. Immunostaining against nestin was only sparsely detectable after 14 days and 
vimentin was immunocytochemically undetectable from day 7 onwards. After 14 days in 
serum free medium immunostaining was undectable against NeuN, sparse against MAP5 and 
NF160, moderate against NSE, but extensive against NF200. 
8DISCUSSION 
Concerning transplantation of immortalized neural progenitors some studies provide very 
strong evidence that the final pathway of their in vivo differentiation is determined by local 
cues provided by the host tissue environment (Lundberg et al., 2002; Macklis, 1993; Renfranz 
et al., 1991; Shihabuddin et al., 1995; Snyder et al., 1997). For clinical application in the 
future great efforts should been made for the development and optimization of appropriate 
protocols for derivation and propagation of the transplanted cells. 
In the present study we investigated further properties of the ST14A-cell line proliferation and 
differentiation in culture up to 14 days with respect to the expression of different specific 
markers for neural progenitor cells or neurons under various culture conditions. Here, we 
show that at the permissive temperature (33C) ST14A-cells exhibit a high proliferative 
ability. The cells also continue to multiply their number at nonpermissive temperature, but the 
proliferation is drastically slowed down. In the serum-free medium at 39C almost the same 
number of cells was found at days 0 and 14. This contrasts with data (Cattaneo & Conti, 
1998), demonstrating that the removal of serum associated with the shift in temperature 
induces cell death within 2-3 days of incubation. However, Cattaneo and Conti investigated 
the cell proliferation for only up to 6 days. Here, we show, that despite a light increase in the 
cell count after 3 days culturing in serum-free medium at 39°C, the comparable cell counts are 
to find at 0 and 14 days of culturing, indicating that proliferation is stopped. At 33°C cells 
expressed the neural progenitor cell markers nestin and vimentin. The elevation of 
temperature to 39C led to a massive decrease of the nestin and vimentin immunoreactivity, 
whereas these markers are still detectable after 14 days, only much less intensively. Some 
studies have shown that immortalized cells, obtained from rodent primary CNS cells retain 
some of the properties of the immature progenitors from which they were derived 
(Frederiksen & McKay, 1988; Mehler et al., 1993). In consistence with this fact, ST14A cells 
partially maintained the expression of nestin and vimentin. Other studies have also provided 
evidences that at the permissivie temperature these cells express nestin and vimentin, whereas 
at the nonpermissive temperature (39°C) in vitro or after transplantation into rodent brain the 
immortalizing oncoprotein is down regulated, the proliferation is reduced followed by a 
decrease of expression of these markers (Cattaneo et al., 1994; Cattaneo & Conti, 1998; 
Lundberg et al., 1997). 
When cultured at 33C in serum-containing medium ST14A-cells were moderate 
immunostained against NSE, NF200, NF160, and sparsely against MAP5. The data from 
9Ehrlich et al. (2001) has also shown that even in the mitotic state these cells expressed NSE 
and ß3 tubulin when grown in FCS-containing medium, indicating that even in the 
immortalized state, ST14A cells are expressing antigens typically characteristic of neurons 
which have progressed beyond the progenitor state. 
In concordance with Cattaneo and Conti (1998) the shift of the temperature to 39°C induced 
cell differentiation, seen in an increasing expression of NSE, NF200, NF160 and MAP5. As 
could be expected, culturing in serum-free medium at the permissive temperature tentatively 
had a comparable effect on ST14A cells differentation: nestin and vimentin expression is 
reduced and neuronal differentiation promoted seen in an increasing expression of NSE, 
NF200, NF160 and MAP5. 
In our study ST14A-cells were never found to be immunopositive for NeuN or MAP2. It is 
known that NeuN does not stain the nuclei of immature nerve cells until they achieve a stage 
of development that at least approaches mature function (Sarnat et al., 1998). Likewise, NeuN 
was not detectable in immortalized CSM14.1-cells by immunohistochemistry, whereas cells 
expressed NeuN as shown by Western-blotting (Haas & Wree, 2002). ST14A-cells were 
found to express MAP2 as shown by Western-blot analysis by Cattaneo and Conti (1998). It 
is known that MAP2 antigen concentration varies with the degree of neuronal maturation and 
dendritic differentiation, and that its expression is proportional to the state of differentiation 
(Sims et al., 1988). In our study cells lack MAP2 and NeuN as shown by 
immunocytochemisty, but express MAP5, a marker which is generally expressed in early 
developmental stages (Bates et al., 1993). We conclude that MAP2 and NeuN are present 
only in low concentrations, indicating that ST14A-cells have not reached late stages of 
differentiation.
Here, we show that additional factors, supporting for the cell differentiation, ST14A cells are 
required for a fully matured neuronal phenotype.
Following intrastriatal grafting only a low number of ST 14A cells (up to 3%) expressed 
MAP2 and expressed neuron-like morphology (Lundberg et al., 1997).
Concerning ST14A-cells the lack of neuronal differentiation of cells in vivo is a major 
limitation of this cell model for transplantation purposes. Nevertheless, by an efficient culture 
procedure ST14A-cells were induced to a stable GABAergic phenotype in vitro and showed a 
long-term survival and phenotype maintenance following transplantation into the adult brain 
in a model of Huntington’s disease (Bosch et al., 2004). 
10
The transfection with genes coding for functionally relevant factors to repair the diseased 
brains also makes this cell line a potential candidate for the implementation of cell 
replacement therapies (Hoffrogge et al., 2007; Pahnke et al., 2004; Weinelt et al., 2003).
If validated for preclinical use, in animal models of neurodegenerative disorders, 
conditionally immortalized ST14A cells could be of great value as they combine proliferative 
properties for the generation of enough cell material with the ability to stop their division at 
the fitting time. 
11
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Fig 1. Proliferation of ST14A cells. A - ST14A cells proliferate extensively at 33°C, 
increasing the cell number from 1206 ± 500 to 6514 ± 2734 in 3 days. At nonpermissive 
temperature (39° C) the proliferation is delayed: the cell number after 14 days is only 9013 ± 
3016.
B - cell division ceases after serum removal, and comparable counts of cells are found at days 
0 (1464 ± 546) and 14 (1421 ± 455). 
17
Fig 2. At 33°C in serum containing medium cells are extensively stained against the 
progenitor cell markers nestin (a) and vimentin (f). Even in these cell culture conditions some 
cells are sparsely stained against neuronal cell marker MAP5 (c). At nonpermissive 
temperature of 39° C cells continue to express MAP5, but much more extensively (d), 
accompanied by a decreasing intensity of the nestin (b) and vimentin (g) stainings. e - 
negative control. Scale bar = 50 μm 
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Abstract
 
Neural stem cell transplantation is a promising strategy for the treatment of neurodegenerative diseases. To
evaluate the differentiation potential of human neural progenitor cells (hNPCs) as a prerequisite for clinical trials,
we intracerebrally transplanted 
 
in vitro
 
 expanded fetal mesencephalic hNPCs into hemiparkinsonian rats. On
postnatal day one (P1), 17 animals underwent a unilateral intraventricular 6-hydroxydopamine injection into the
right lateral ventricle. At P3, animals (
 
n
 
 = 10) received about 100 000 hNPCs (1 
 
μ
 
L) in the right striatum. Five weeks
after birth, animals underwent behaviour tests prior to fixation, followed by immunohistochemistry on brain
slices for human nuclei, glial fibrillary acidic protein, S100
 
β
 
, neuronal nuclei antigen, neuron-specific enolase and
tyrosine hydroxylase. Compared with the apomorphine-induced rotations in the lesioned-only group (7.4 
 
±
 
 0.5 min
 
−
 
1
 
),
lesioned and successfully transplanted animals (0.3 
 
±
 
 0.1 min
 
−
 
1
 
) showed a significant therapeutic improvement.
Additionally, in the cylinder test, the lesioned-only animals preferred to use the ipsilateral forepaw. Conversely,
the lesioned and transplanted animals showed no significant side bias similar to untreated control animals.
Transplanted human nuclei-immunoreactive cells were found to survive and migrate up to 2000 
 
μ
 
m into the host
parenchyma, many containing the pan-neuronal markers neuronal nuclei antigen and neuron-specific enolase. In the
striatum, tyrosine hydroxylase-immunoreactive somata were also found, indicating a dopaminergic differentiation
capacity of transplanted hNPCs 
 
in vivo
 
. However, the relative number of tyrosine hydroxylase-immunoreactive neurons
 
in vivo
 
 seemed to be lower than in corresponding 
 
in vitro
 
 differentiation. To minimize donor tissue necessary for
transplantation, further investigations will aim to enhance dopaminergic differentiation of transplanted cells 
 
in vivo
 
.
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Introduction
 
Parkinson’s disease (PD) is a slowly progressive degenera-
tive disorder of the central nervous system (CNS), caused
by the chronic loss of dopaminergic (DAergic) neurons
in the substantia nigra and subsequently depletion of
dopamine in the striatum, the main projection area of
the substantia nigra (Bernheimer et al. 1973; Hirsch et al.
1988). As the loss of striatal dopamine causes PD
symptoms, most drugs used to treat PD are aimed at the
replenishing of dopamine. DAergic drugs are generally
effective at first in reducing many PD symptoms, but
lose their effect over time and have severe side-effects
(Clarke & Guttman, 2002).
Over the past two decades, cell replacement therapy
has become a promising approach for the treatment of
neurological diseases, including PD (Björklund & Lindvall,
2000). Clinical investigations and studies on animal
models have shown that cell grafts can functionally
integrate and restore dopamine release (Freed et al.
2001; Hagell & Brundin, 2001; Burnstein et al. 2004).
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The current primary treatment strategies focused on
cells with potential to differentiate into DAergic neurons
(Roybon et al. 2004).
Stem cells are immature, unspecialized cells that have
the ability to renew themselves indefinitely, and, under
appropriate conditions, can give rise to a wide range
of mature cell types. Multipotent neural stem cells can
be derived from the subventricular zone or germinal
matrix of the developing fetal brain and develop into
neurons, astrocytes and oligodendrocytes (Snyder
et al. 1992). Neural progenitor cells (NPCs) have been
demonstrated to be a population with self-renewal and
multidifferentiation properties (McKay, 1997). Under
certain conditions, these cells can be controlled to
differentiate into specific neuronal phenotypes, such
as DAergic neurons (Studer et al. 1998). Relatively little
is known about human progenitor cells, because
most studies have used progenitor cells obtained from
rodents (Li et al. 2003; Sun et al. 2003). Human neural
progenitor cells (hNPCs) can be expanded in large
numbers for significant periods of time to provide a
reliable source of neural cells for transplantation in
neurodegenerative disorders such as PD.
A few studies have reported therapeutic effects of
transplantation of NPCs from human sources in animal
models (Ben-Hur et al. 2004; Yang et al. 2004). Mesen-
cephalic NPCs are considered to be the most suitable
candidates for cell replacement therapy for treating
PD, because some researchers have shown that, compared
with those from other brain areas, these NPCs dif-
ferentiated with higher probability into DAergic
neurons after transplantation (Svendsen et al. 1996). The
main problems in progenitor grafting in PD are (1) the
low rate of cell survival after transplantation and (2)
the small percentage of those converting into the DAe-
rgic phenotype, suggesting that environmental factors
or epigenetic stimulations are needed to support
the survival, differentiation and integration processes.
Strategies to improve the survival and differentiation
of mesencephalic progenitors include (1) genetic
modification, (2) pretreatment with growth factors,
antioxidants and cytokines, and (3) modified implanta-
tion procedures (Brundin et al. 1986; Nakao et al. 1994;
Yurek et al. 1996; Carvey et al. 2001; Kodama et al. 2004).
Among those manipulations, growth factors in particular
regulate neural stem cell behaviour. During development,
growth factors provide important extracellular signals for
regulating the proliferation and fate determination of
stem and progenitor cells in the CNS (Calof, 1995).
In the present study, hNPCs were propagated 
 
in vitro
 
in the presence of epidermal growth factor (EGF) and
fibroblast growth factor 2 (FGF-2). 
 
In vitro
 
 studies have
shown that both factors can maintain responsive
neural progenitors in the cell cycle, thus expanding
the progenitor population and delaying differentiation
(Bouvier & Mytilineou, 1995).
After 
 
in vitro
 
 expansion we transplanted hNPCs derived
from the ventral mesencephalon of an 8-week-old
embryo into the DAergic deafferentiated striatum of
neonatal rats. The aim of our study was to characterize
(1) the differentiation of hNPCs after transplantation
into the striatum of neonatal hemiparkinsonian rats,
and (2) the possible therapeutic benefit.
 
Materials and methods
 
Isolation and 
 
in vitro
 
 expansion of 
mesencephalon-derived hNPCs
 
The isolation and propagation of hNPCs were in
accordance with the Ethical Principles for Medical
Research involving Human Subjects of the Declaration
of Helsinki and were approved by the local ethics com-
mittee and that of the University of Rostock. Isolation
and propagation of cells were essentially as described
for retinal precursors (Andressen et al. 2003). In brief,
the ventral midbrain (one individual from the 8th week
of gestation) was dissected, including the subependymal
regions. For the expansion of precursor cells, tissue
samples were cut into small pieces, incubated in Hanks’
buffer (HBSS) including 0.1% trypsin/EDTA (Invitrogene,
Germany) for 30 min at room temperature. A single cell
suspension was achieved by gentle trituration using a
fire-polished Pasteur pipette. After sedimentation of
the tissue debris by gravity, cells in the supernatant were
collected, centrifuged, resuspended and transferred to
culture dishes coated with poly-
 
L
 
-lysine (PLL, 10 
 
μ
 
g
mL
 
−
 
1
 
 cm
 
−
 
2
 
) followed by laminin-1 (2 
 
μ
 
g mL
 
−
 
1
 
 cm
 
−
 
2
 
). Cells
were placed in a humidified incubator at 37 
 
°
 
C, 5% CO
 
2
 
in air and cultivated in serum-free Dulbecco’s modified
Eagle’s medium (DMEM) (high glucose)/F-12 medium
mixture (1 : 1), supplemented with transferrin (100 mg
mL
 
−
 
1
 
), insulin (25 mg mL
 
−
 
1
 
), progesterone (20 n
 
M
 
),
putrescine (62 m
 
M
 
) and sodium selenite (30 n
 
M
 
).
Additionally, 20 ng mL
 
−
 
1
 
 of human recombinant EGF
and FGF-2 were added to the medium (all supplements
from Sigma, Germany). Cells were cultivated replenishing
half of the medium every second day. Before reaching
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confluence, cells were passaged by careful trituration
in Ca
 
2+
 
/Mg
 
2+
 
-free, 0.1% EDTA containing HBSS using
a fire-polished Pasteur pipette starting at a density
of 5 
 
×
 
 10
 
4
 
 cells mL
 
−
 
1
 
. Neural progenitor phenotype was
assessed routinely by immunocytochemistry for Nestin
and Vimentin.
Proliferating Nestin- and Vimentin-containing hNPCs
were expanded for 6 months with passaging every 8th
 
−
 
10th day (19 passages). To allow mesencephalic hNPCs
to predifferentiate, cells were cultivated in serum-free,
20 ng mL
 
−
 
1
 
 human EGF and FGF-2 containing prolifera-
tion medium in bacteriological (non-adherent) dishes
to generate neurospheres. This technique has recently
been shown to mimic the three-dimensional situation
in the developing CNS (Miyata et al. 2001; Campos et al.
2004). After 6 days, spheres were collected, and tritu-
rated to generate single cell suspensions for (1) trans-
plantation or (2) further 
 
in vitro
 
 analysis. For the latter,
suspended cells were again allowed to form spheres for
a further 5 days (serum-free medium, without human
EGF and FGF-2) which were then plated on PLL/laminin-
1-coated glass cover slips to allow adherence for a further
24 h, followed by immunocytochemical examination
with antibodies against the neuronal markers MAP5
and tyrosine hydroxylase (TH).
 
Animals
 
A total of 27 female Wistar rats were used in the experi-
ment. Three groups were investigated: (1) intact controls
(
 
n
 
 = 10), (2) lesioned-only rats (
 
n
 
 = 7), and (3) lesioned
and transplanted rats (
 
n
 
 = 10). Animals were housed at
22 
 
±
 
 2 
 
°
 
C under a 12-h light/dark cycle with free access
to food and water, first with their mothers, then in
groups of 4–6 per cage. All animal-related procedures
were conducted in accordance with local ethical guidelines
and approved animal care protocols.
 
Neonatal 6-OHDA lesions
 
The hemiparkinsonian neonatal rats (
 
n
 
 = 17) were
generated by unilateral (right) intraventricular injec-
tion of 2 
 
μ
 
L 6-OHDA-HCl (Sigma, 120 
 
μ
 
g/10 
 
μ
 
L 6-OHDA-
HCl in 0.9% NaCl solution, containing 0.2 mg mL
 
−
 
1
 
 ascorbic
acid) on postnatal day one (P1), using the coordinates
(relative to bregma): AP 
 
−
 
0.6, L 
 
−
 
0.8, V 
 
−
 
2.1 (dura). Details
of the handling and the operative procedures by using
a neonatal stereotaxic device (Stoelting Co., Wood Dale,
IL, USA) are described in detail elsewhere (Cunningham
& McKay, 1993). The neurotoxin 6-OHDA induces rapid
cell death of DAergic neurons within 1–3 days (Shimohama
et al. 2003).
 
Cell transplantation
 
Intrastriatal stereotaxic transplantation was conducted
on lesioned animals (
 
n
 
 = 10) at P3. About 100 000 pre-
differentiated viable cells (1 
 
μ
 
L suspension) from the
19th passage were transplanted into the right striatum
by using a glass capillary with an outer diameter of 50–
70 
 
μ
 
m connected to a 5-
 
μ
 
L Hamilton microsyringe. The
coordinates from bregma were set as: AP +0.7, L 
 
−
 
1.8,
V 
 
−
 
2.9 (dura), according to Nikkhah et al. (1995a,b).
 
Behavioural assessments
 
For the lesioned and transplanted group (
 
n
 
 = 10), only
those animals were included in the statistics for behaviour
tests where the graft position was centred exactly in the
striatum, as confirmed by immunohistochemistry (
 
n
 
 = 5).
 
Apomorphine-induced rotations
 
Five weeks after transplantation lesioned-only animals
(
 
n
 
 = 7) and lesioned and transplanted animals (
 
n
 
 = 5)
were tested for apomorphine-induced contralateral
rotations (0.25 mg kg
 
−
 
1
 
, s.c., Teclapharm, Germany). Their
mean net contralateral rotations were collected for
40 min using a self-constructed automated rotometer
system as described by Ungerstedt & Arbuthnott
(1970).
 
Cylinder test
 
At the same time point, forelimb preference was
evaluated with the cylinder test in intact control
(
 
n
 
 = 10), lesioned-only (
 
n
 
 = 7), and lesioned and trans-
planted (
 
n
 
 = 5) animals. The use of the forepaws during
vertical exploration in a glass cylinder with a diameter
of 20 cm was documented and analysed with a video
camera system (Sony) as described by Kirik et al. (2000).
Thirty consecutive forepaw contacts with the glass
cylinder were counted per animal and differences
between the right and left paw were evaluated for all
three groups. To prevent subjective bias, contacts made
by each forepaw with the cylinder wall were scored
from the videotapes by an observer blinded to the
animals’ identities.
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Immunohistochemistry
 
For 
 
in vitro
 
 immunohistochemistry cells were fixed
for 20 min with 4% paraformaldehyde in 0.1 
 
M
 
 PBS.
After preincubation with 10% blocking serum for
1 h, the cultures were stained with antibodies to Nestin
(1 : 500, Chemicon), Vimentin (1 : 200, Sigma) or double-
stained with antibodies to MAP5 (1 : 500, Sigma) and
TH (1 : 500, Sigma). CY2- (1 : 400) and CY3- (1 : 500)
conjugated secondary antibodies (both Dianova) were
used for visualization. Preparation of the animals for
immunohistochemistry was performed 6 weeks after
birth. Rats were injected with an overdose of pento-
barbital (60 mg kg
 
−
 
1
 
) and transcardially perfused with
ice-cold 0.9% sodium chloride (50 mL), followed by
300 mL of 3.7% paraformaldehyde (dissolved in 0.1 
 
M
 
PBS, pH 7.4). Brains were immediately removed from
the skull, post-fixed for 4 h, and transferred into PBS
(pH 7.4) containing 20% sucrose (overnight, 4 
 
°
 
C). The
cryoprotected brains were frozen in isopentane (
 
−
 
50 
 
°
 
C)
and stored at 
 
−
 
80 
 
°
 
C until further processing.
Brains were cut with a cryostate at 30 
 
μ
 
m and serial
sections were collected. For free-floating immunohis-
tochemical stainings using 3,3
 
′
 
-diaminobenzidine (DAB),
sections were pretreated with 3% H
 
2
 
O
 
2
 
 to quench
endogenous peroxidases, then blocked with 3% bovine
serum albumine (BSA), normal horse serum (1 : 67,
polyclonal, Vector Laboratories) and 0.05% Triton-X100
for 1 h, and subsequently incubated with mouse anti-
human nuclei (HN; 1 : 400, monoclonal, Chemicon) or
mouse anti-TH (1 : 1000, monoclonal, Sigma) primary
antibodies overnight at 4 
 
°
 
C. Then sections were
washed three times in PBS and incubated with biotinylated
horse anti-mouse secondary antibody (1 : 200, Vector)
overnight at 4 
 
°
 
C. After three rinses in PBS, sections
were incubated with peroxidase-conjugated avidin–
biotin complex (1 : 50, Vector Laboratories) for 2 h at
room temperature, washed three times in PBS, followed
by incubation with 0.02% DAB for 8 min at room
temperature. Mounted sections were dehydrated through
a graded series of alcohol and embedded in DePeX
mounting medium (Serva).
For immunofluorescence, after preincubation in
3% BSA, 5% normal goat serum and 0.05% Triton-X100
(2 h), all sections were stained with mouse anti-HN
(1 : 200) together with the following polyclonal primary
antibodies overnight at 4 
 
°
 
C: rabbit anti-neurofilament
200-kDa (NF 200, 1 : 100, Sigma), rabbit anti-neuron-
specific enolase (NSE, 1 : 800, Chemicon), rabbit anti-S100
 
β
 
(1 : 100, Sigma) or rabbit anti-glial fibrillary acidic protein
(GFAP, 1 : 100, Sigma). For antigen visualization, anti-
mouse CY3- (goat, red fluorescence, 1 : 500, Dianova),
anti-rabbit CY2- (donkey, green fluorescence, 1 : 400,
Dianova) or anti-rabbit AMCA- (goat, blue fluorescence,
1 : 100, Dianova) conjugated secondary antibodies were
applied. The sections stained with anti-HN and anti-
GFAP (detected with CY3- and AMCA-conjugated
antibodies) were finally incubated with FITC-conjugated
anti-neuronal nuclei (NeuN) (mouse, 1 : 200, Chemicon)
for neuronal phenotype detection of transplanted
human cells. It was not possible to detect HN and TH
simultaneously by immunoflourescent stainings, because
both primary antibodies used in our laboratory were
derived from the same host species (mouse).
Micrographs were taken via confocal laser scanning
microscopy (CLSM), and bright-field microscopy. The
24-bit RGB micrographs derived from CLSM were
segmented by applying the global intensity-based
algorithm of Otsu (1979) to filter background staining.
 
Results
 
In vitro
 
 characterization of hNPCs
 
After dissection of the ventral mesencephalon followed
by trituration, selection in proliferation medium
containing the mitogens FGF-2 and EGF resulted in
adherence of neuroepithelial cells to the coated
culture dish. Neuroepithelial cells proliferated for 19
passages and expressed the intermediate filament
proteins Nestin (not shown) and Vimentin (Fig. 1A).
Under these conditions, a continuous proliferation
was observed for at least 6 months, with no differences
in proliferation and morphology of precursor cells.
In the experiments parallel to the transplantation,
immunohistochemical analysis of cells that were
allowed to form spheres revealed that a high number
of them expressed the neuronal marker MAP5 (Fig. 1B).
Some of these MAP5-immunoreactive (ir) neurons
were considered to be of DAergic phenotype, as they
also synthesized TH (Fig. 1B).
 
Behavioural recovery of hemiparkinsonian rats
 
For apomorphine-induced rotations, two groups of
rats were tested (lesioned-only, and lesioned and
transplanted). The results are summarized in Fig. 2(A).
In the lesioned-only group rats displayed rotations in
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the direction contralateral to the lesion (7.4 
 
±
 
 0.5 min
 
−
 
1
 
),
consisting of a rapid and nearly complete depletion of
DAergic neurons in the midbrain and deafferentia-
tion of the striatum after 6-OHDA administration
(Shimohama et al. 2003). By contrast, the lesioned
and transplanted rats displayed significantly fewer
rotations per minute, decreasing the number of
rotations to 0.3 
 
±
 
 0.1 min
 
−
 
1
 
 (
 
P =
 
 0.001, 
 
U
 
-test).
The cylinder test was performed on thr three groups
of rats (intact control, lesioned-only, and lesioned and
transplanted) (Fig. 2B). In the group of intact controls
the number of touches performed by right and left
forepaws was nearly identical (right to left ratio:
14.2 
 
±
 
 0.2–15.8 
 
±
 
 0.2). However, hemiparkinsonian rats
showed a significant impairment in their left paw use
(right to left ratio: 16.9 
 
± 0.4–13.1 ± 0.4). By contrast,
the lesioned and transplanted animals again showed
no significant side bias, the right to left ratio being
15.8 ± 0.5–14.2 ± 0.5 (P = 0.05, Wilcoxon-test), thus
matching intact controls.
Survival, migration and differentiation of 
transplanted cells
Light microscopic analysis of TH-immunostained
brain sections of 6-OHDA-lesioned animals revealed
an almost complete depletion of TH-ir terminals in the
right striatum (Fig. 3A) due to loss of DAergic neurons
of the ipsilateral midbrain (Fig. 3B). For the lesioned
and transplanted group five animals were excluded
from the statistics due to ectopic localization (n = 2) or
lack of HN-ir cells (n = 3), whereas successfully positioned
hNPCs grafts centred in the striatum were found in
five animals as assessed by HN immunohistochemistry
(Fig. 4). Most of the transplanted hNPCs were confined
Fig. 1 Proliferation and differentiation of mesencephalic hNPCs 
in vitro. When cultured in serum-free medium supplemented 
with EGF and FGF-2 most cells expressed Vimentin (A). In 
plated spheres differentiated cells coexpressed MAP5 (green) 
and TH (red) as revealed by double immunocytochemistry (B). 
Note that the MAP5-staining intensity was electronically 
reduced in favour of TH-staining. Scale bars = 100 μm.
Fig. 2 Behavioral analysis. Apomorphine-induced rotations 
in lesioned-only animals (n = 7) were 7.4 ± 0.5 min−1, whereas 
the rotation score in lesioned and transplanted animals (n = 5) 
was significantly lower (0.3 ± 0.1 min−1; P = 0.001, U-test) (A). 
The forelimb preference tests in intact controls displayed no 
significant side bias (right to left ratio: 14.2 ± 0.2–15.8 ± 0.2), 
whereas lesioned-only animals displayed a significant 
(P = 0.05, Wilcoxon-test) right forepaw preference (right 
to left ratio: 16.9 ± 0.4–13.1 ± 0.4). However, lesioned and 
transplanted animals exhibited no significant differences 
in forepaw use (right to left ratio: 15.8 ± 0.5–14.2 ± 0.5) (B).
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to the striatum and loosely scattered around the
injection site (Fig. 4A,B). However, some grafted cells
migrated up to 2000 μm to the subependymal region
of the lateral ventricle or along the corpus callosum
(Fig. 4C). In the centre of the transplant (Fig. 4B) as
well as in the surrounding area (Fig. 4D), in the corpus
callosum (Fig. 4E) and the subependymal region (Fig. 4F)
cells with different nuclear morphologies were detected.
HN-ir cells in the white matter showed elongated nuclei
parallel to the host fibre tracts, while cells concentrated
within the grey matter exhibited mostly large round
nuclei.
Multipotent differentiation of grafted cells was
confirmed by double-immunofluorescent staining and
confocal microscopy (Fig. 5A–F). A large number of HN-
ir cells were detected in the striatum around the needle
track (Fig. 5A). Double staining with HN paired with
the mature neuronal marker NeuN revealed a con-
siderable number of human cells with neuronal pheno-
type (Fig. 5B–D). The neuronal phenotype of grafted
cells was also confirmed by the neuronal marker NSE
(Fig. 5E) and NF 200 (not shown). Three-dimensional
confocal analysis also revealed cells of human origin
expressing astroglial markers GFAP (Fig. 5F) or S100β
(not shown).
TH immunohistochemistry showed transplanted human
progenitor cells converted into a DAergic phenotype
in vivo located mostly in the periphery of a graft. TH-
positive cells with clearly delineated processes, ramifying
and extending in different directions, were only found
in the striatum of lesioned and subsequently transplanted
animals (Fig. 6A–C), but never in lesioned-only rats.
Discussion
Over recent decades, transplantation of fetal dopaminergic
tissue into the denervated striatum has been considered
as an approach for replenishing striatal dopamine levels
and reforming the nigrostriatal pathway (Björklund
& Lindvall, 2000). Having the capacity of both self-
renewal and multiple differentiation, NPCs are an
appropriate source of cells for clinical application and offer
a promising future for cell replacement therapies (Gage,
2000). There have been many studies on the transplanta-
tion of animal-derived neural progenitors, whereas the
therapeutic efficacy of NPCs of human origin has seldom
been discussed. For clinical treatment of PD, however,
an important goal is the generation of large numbers of
graftable neurons from expanded human cultures.
In the experiment presented here, we transplanted
hNPCs derived from the ventral mesencephalon of an
8-week-old embryo. These progenitors, with the capacity
to proliferate and differentiate, have paramount potential
for use in transplantation therapies for the treatment
of neurodegenerative diseases. It has already been
reported (Carpenter et al. 1999) that hNPCs exist in the
first trimester and can be expanded in vitro, maintaining
the capacity to differentiate into neurons, astrocytes
and oligodendrocytes. This expansion depends on
mitogens and does not require genetic modification
of the cells. A number of growth factors support the
proliferation of neural precursor cells and the differen-
tiation of their progenitors. Growth factors not only carry
out a traditional mitogenic function, but also enhance
survival of dividing precursors (Kwon, 2002).
In particular, EGF and FGF-2 have been found to stimu-
late the division of embryonic or adult CNS precursors
(Kilpatrick et al. 1995). To generate sufficient numbers
of hNPCs from a limited amount of fetal mesencephalic
tissue, we expanded human progenitors for 6 months
in a medium containing FGF-2 and EGF (Chalmers-
Redman et al. 1997; Svendsen et al. 1998). Removal of
Fig. 3 Immunocytochemical TH-staining of the striatum and 
ventral mesencephalon including the substantia nigra of a 
hemiparkinsonian rat. The unilateral 6-OHDA lesion resulted 
in a depletion of the TH-positive fibres in the striatum (A) due 
to a profound DAergic cell loss in the substantia nigra (B). 
Scale bars = 1000 μm (A) and 500 μm (B).
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Fig. 4 Survival and migration of 
grafted hNPCs in hemiparkinsonian rats. 
Transplanted cells were detected by 
HN staining (A–F). Most cells were 
confined to the striatum (A–C), some 
cells migrated to the lateral ventricle 
and corpus callosum (C). D–F show 
enlargements of boxes outlined in C. 
Scale bars = 500 μm (A,C) and 50 μm 
(B,D–F).
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mitogens and addition of serum result in the differ-
entiation of the progenitor cells into neurons and glia
(Vescovi et al. 1999). The first steps of this differentiation
were allowed to take place in spheres that are known
to develop a three-dimensional structure with a cellu-
lar distribution and extracellular matrix composition
similar to that of the developing neuroepithelium
(Campos et al. 2004).
To determine whether transplanted cells led to a
behavioural improvement, two behavioural assessment
tests were performed: the apomorphine-induced
rotation test and the cylinder test. The apomorphine-
induced rotation scoring test relies on apomorphine
stimulating supersensitive dopamine receptors in the
dopamine-denervated striatum, which induces con-
tralateral rotations in the rat. In this regard, the average
rotation score in the lesioned-only rats (7.4 min−1) is
indicative of a unilateral loss of about 95% of the
DAergic neurons in the substantia nigra (Ungerstedt &
Arbuthnott, 1970), although structural perturbations
in the striatum caused by cannulas or inflammation
can make this test of apomorphine-induced behaviour
unreliable (Dunnett et al. 1988; Jeyasingham et al. 2001).
In accordance with other reports of microtransplantation
Fig. 5 Grafted hNPCs in hemiparkinsonian 
rats. HN-ir cells (red fluorescence) are 
confined to the striatum, counterstained 
with anti-NeuN (green fluorescence) (A). 
The differentiation of grafted hNPCs 
into neurons was revealed with NeuN 
(green) (B) and HN (red) (C). The co-
localization (yellow) became obvious in 
the merged image (D). NSE (green) and 
HN (red) double labelling is shown in E. 
Astroglial differentiation of grafted cells 
was confirmed by staining with HN (red) 
paired with the astroglial marker GFAP 
(green) (F). Arrows in E and F indicate 
double labelled cells. Scale bars = 50 μm 
(A–F).
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technique minimizing brain damage to overcome this
limitation (Nikkhah et al. 1995a,b), we also performed
microtransplantation using glass capillaries with an
outer diameter of about 50–70 μm.
In addition, we used the cylinder test for the further
evaluation of motor behaviour. Whereas intact control
animals showed no preference in forepaw use, lesioned-
only animals exhibited a significant impairment in the
use of the left (contralateral) forepaw. It is well known
for rats and mice lesioned as adults that a significant
impairment in skilled paw use appears only after a cell
loss in the range 60–80% of DAergic neurons in the sub-
stantia nigra (Espejo et al. 2001; Iancu et al. 2005), resulting
in an 80–90% loss of DAergic fibres in the striatum (Lee
et al. 1996). Compared with cylinder test experiments
using adult hemiparkinsonian animals (Kirik et al. 2000),
the observed side bias in the lesioned-only group was
low, but significant. One possible explanation for this
phenomenon could be a higher plasticity of the juvenile
brain resulting in a compensatory effect of motor
deficits in the extrapyramidal system.
Transplantation of hNPCs led to a significant improve-
ment of motor behaviour in both tests. Mild improvements
in motor behaviour were found after transplantation
of non-neural cells (Shults et al. 2000), but in our study
the improvement correlated with TH-ir cells with
massive outgrowths detected in the right striatum of
the lesioned and transplanted animals. Normally there
are no DAergic neurons in the striatum of rats (Betarbet
et al. 1997). Thus, the TH-ir cells seen in the striatum of
transplanted animals must be derived from the grafted
human cells. Moreover, we never observed TH-ir cells in
the caudate putamen of lesioned-only animals.
In experimental animals there is a documented
correlation between the numbers of surviving DAergic
neurons in grafts and the degree of restoration of
behavioural deficiencies due to lesions of the nigros-
triatal pathway (Chaturvedi et al. 2003; Wang et al. 2004).
In our experiment, the marked behavioural improvement
(the decrease of rotational score from 7.4 ± 0.5 min−1
in lesioned-only rats to 0.3 ± 0.1 min−1 in lesioned and
transplanted rats) was apparently caused by a relatively
low number of TH-positive cells. It should be noted,
however, that graft-derived TH-ir cells had clearly
delineated outgrowths extending into the host striatum.
Notably, Freed et al. (1981) showed that adrenal
medulla tissue implanted in the lateral ventricle
adjacent to the deafferentiated striatum had the
capacity to reduce apomorphine-induced rotations
even in the absence of any evidence of fibre re-
innervation of the host brain.
Immunofluorescent analysis revealed convincingly
that most of the transplanted cells became post-mitotic
Fig. 6 Dopaminergic differentiation of grafted hNPCs. TH-ir 
cells with obvious processes were found in the right (lesioned 
and transplanted) striatum (A–C). Scale bars = 50 μm.
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neurons, as shown by NeuN, NSE or NF 200 immunoreac-
tivity. A profound population of HN-ir cells was found
to express the astrocyte-specific marker GFAP (or S100β).
Notably, the vast majority of grafted cells positive for
either neuronal or astroglial markers were found
preferentially within the striatum. By contrast, cells
which displayed extensive migration tendency, reaching
the subependymal zone of the lateral ventricle and
the corpus callosum, were negative for NeuN and GFAP
(and S100β). Although it may be possible to detect
oligodendroglial differentiation in the white matter, a
similar study of the transplantation of human mesen-
cephalic progenitors into the neonatal brain has shown
that none of the migrated cells expressed appropriate
markers (Englund et al. 2002). Our results of neuronal
or astroglial differentiation detected preferentially
in the striatum around the injection site correlate with
those obtained after the grafting of human cells into
the unlesioned developing rat striatum and hippo-
campus (Rosser et al. 2000). Accordingly, we also consider
that cells that have migrated from the injection site are
a population of as yet undifferentiated cells. It is note-
worthy that in our study this population was relatively
small. By contrast, for adult rats a larger number of
undifferentiated cells have been described after trans-
plantation (Fricker et al. 1999), focusing on the role of
local environmental factors for neuronal differentia-
tion. This view of the neonatal brain as a more permissive
environment has recently been extended on dopaminergic
differentiation of transplanted mesencephalic progenitors
(Grothe et al. 2004). However, in our experiments,
the rate of TH-ir neurons after transplantation into
the striatum was found to be lower than expected from
parallel in vitro differentiation, indicating that even the
developing striatum is not an ideal environment for
the generation of this neuronal subtype.
To overcome these limitations, cytokines and/or
neurotrophic factors have been used to increase the
number of pre-DAergic hNPCs in vitro before transplan-
tation (Storch et al. 2001). Bearing in mind the poor
differentiation of progenitors into DAergic cells in vivo,
future studies will look at the role of local environ-
mental cues for the induction and/or survival of certain
types of neurons. The importance of the environment
as a master regulator for DAergic differentiation will be
assessed by orthotopic transplantation of mesencephalic
hNPCs into the substantia nigra.
In summary, our results show that mesencephalic
hNPCs can be isolated and subsequently propagated in
culture using mitogens. These cells have the capacity to
migrate and differentiate partially into neurons and
glia when transplanted into the unilaterally lesioned
neonatal rat brain. In spite of the marked neuronal dif-
ferentiation and behavioural improvement observed,
the number of surviving DAergic neurons in grafts
was low. Taking the correlation between the number
of DAergic neurons and behavioural outcome as a
key hypothesis, strategies to improve th former will
need to be developed to reach clinical applicability.
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tion, glial fibrillary acidic protein-expressing cells were also 
detected. Our results show that behavioral improvement 
does not necessarily correlate with a differentiation of trans-
planted precursors into dopaminergic neurons, indicating 
other factors to be involved in a partial functional recovery. 
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 Abstract 
 The clinical outcome of cell replacement therapies depends 
upon the successful survival and differentiation of trans-
planted cells. Here, we transplanted human neural progen-
itor cells derived from the ventral mesencephalon of an
8-week-old embryo into the ipsilateral (right) striatum of 
unilateral 6-hydroxydopamine-lesioned adult rats. To assess 
the therapeutic potency of grafted cells, 2 independent be-
havioral tests were conducted 12 weeks after transplanta-
tion: in the rotation test, a mild behavioral improvement
was detected, and in the cylinder test, transplanted animals 
overcame the lesion-induced right forepaw preference. To 
address this behavioral improvement to a dopaminergic dif-
ferentiation capacity of transplanted cells in vivo, immuno-
histochemistry for tyrosine hydroxylase was performed, 
showing a total lack of immunoreactivity. However, we found 
a considerable number of transplanted human nuclei-posi-
tive cells preferentially differentiated into neurons. In addi-
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Abbreviations used in this paper
6-OHDA 6-hydroxydopamine
BSA bovine serum albumin
CNS central nervous system
DA dopamine
DAB diaminobenzidine
DAergic dopaminergic
DMEM Dulbecco’s modified Eagle’s medium
EGF epidermal growth factor
FGF-2 fibroblast growth factor-2
GDNF glial cell line-derived neurotrophic factor
GFAP glial fibrillary acidic protein
HN human nuclei
hNPCs human neural progenitor cells
ir immunoreactive
NeuN neuronal nuclei
NF 200 neurofilament 200 kDa
NPCs neural progenitor cells
PBS phosphate-buffered saline
PD Parkinson’s disease
SEM standard error of the mean
TH tyrosine hydroxylase
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Nevertheless, for the development of a clinically useful cell 
therapy, it is important to overcome obstacles, namely the 
poor dopaminergic differentiation of human neural progen-
itor cells after grafting.  Copyright © 2008 S. Karger AG, Basel 
 Introduction  
 Parkinson’s disease (PD) is a neurodegenerative dis-
order characterized by a relatively selective loss of
midbrain dopaminergic (DAergic) neurons, with sub-
sequent reductions in striatal dopamine (DA) levels 
[Hirsch et al., 1988]. The decline of DA in the striatum 
is associated clinically with progressive bradykinesia, 
tremor, rigidity and postural instability [Tedroff et al., 
1999]. The primary PD treatment strategy involves a 
pharmacological approach to supply the missing neu-
rotransmitter DA. The precursor of DA,  L -3,4-dioxy-
phenylalanine, is currently the most effective therapeu-
tic drug for alleviating PD symptoms. Unfortunately, 
 L -3,4-dioxyphenylalanine slowly becomes less effective 
after long-term treatment and shows undesirable side 
effects [Fahn et al., 2004]. 
 Clinical trials with neural transplantation have dem-
onstrated the efficacy of primary human fetal neural 
tissue grafts in PD [Lindvall and Björklund, 2004].
However, there are several problems related to the use of 
this technique, including poor availability of sufficient 
quantities in combination with poor survival of trans-
planted cells limiting the widespread clinical applica-
tion of neural transplants [Freed et al., 2003; Olanow et 
al., 2003]. 
 An alternative strategy is the use of neural progenitor 
cells (NPCs), enabling the expansion in vitro to obtain 
large numbers of cells for transplantation. Additionally, 
these cells can be standardized, screened and manipu-
lated prior to transplantation. Progenitor cells are func-
tionally immature, self-renewing cells which, in contrast 
to the stem cells from which they are derived, are lineage 
restricted [McKay, 1997]. NPCs possessing the capacity 
to differentiate into all major cell types of the mature cen-
tral nervous system (CNS) have been isolated from the 
developing or adult CNS [Weiss et al., 1996; Luskin et al., 
1997; Temple and Alvarez-Buylla, 1999]. They can be ex-
panded in vitro in the presence of mitogenic factors to 
provide much larger numbers of cells available for trans-
plantation [Reynolds et al., 1992]. NPC proliferation is 
mediated and influenced by many growth factors, espe-
cially epidermal growth factor (EGF) and fibroblast 
growth factor-2 (FGF-2) [Kilpatrick and Bartlett, 1995; 
Tropepe et al., 1999]. Aiming at a significant restoration 
of striatal DA levels, the ventral mesencephalic area of the 
brain is suggested as an important source of NPCs suit-
able for the cell replacement therapy of PD [Lindvall and 
Björklund, 2004]. A therapeutic outcome, however, is 
thought to be dependent on the viability of NPCs that are 
destined to become DAergic neurons. Unfortunately, 
only a small fraction (about 5–10%, or even less of the 
progenitors), that are destined to become DAergic neu-
rons, survives the grafting procedure [Brundin et al., 
2000b].
 For rat midbrain NPCs, it has been shown that they 
can proliferate and differentiate in vitro into DAergic 
neurons and, moreover, that the transplantation of these 
cells leads to a recovery in a rat model of PD [Studer et 
al., 1998]. Presently, there are only few reports about 
transplantation of human NPCs (hNPCs) derived either 
from embryonic stem cells [Ben Hur et al., 2004] or from 
fetal brain [Sanchez-Pernaute et al., 2001; Wang et al., 
2004; Christophersen et al., 2006] into adult lesioned an-
imals. Noteworthy, the number of surviving cells and 
their differentiation into tyrosine hydroxylase (TH)-im-
munoreactive (ir) cells varies widely, ranging from lack 
[Wang et al., 2004] to up to 1,000 cells per graft [Sanchez-
Pernaute et al., 2001], depending on the expansion pro-
tocol and transplantation procedure. In addition, also 
the environment may play a crucial role in survival, mi-
gration and differentiation of transplanted cells. Here, 
we transplanted hNPCs derived from the ventral mesen-
cephalic area of an 8-week-old human embryo into a DA-
depleted striatum of adult rats. These cells have previ-
ously been shown to differentiate into TH-ir neurons ac-
companied by a behavioral benefit when transplanted 
into the lesioned striatum of juvenile animals [Hovaki-
myan et al., 2006]. In contrast to juvenile recipients, in 
the present parallel study, hNPC differentiation into 
DAergic neurons was not found, supporting the view of 
the environment as an instructive cue for neuronal spec-
ification and differentiation. Interestingly, we observed 
an almost complete functional recovery in the absence 
of DAergic innervation in the cylinder test. In the apo-
morphine-induced rotation test, again a mild improve-
ment in the transplantation group was observed, where-
as the sham control animals showed a progressive sig-
nificant impairment. Our results suggest factors derived 
from transplanted hNPCs to be responsible for differ-
ences between the 2 groups. 
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 Materials and Methods  
 In vitro Analysis 
 Isolation and in vitro Expansion of Mesencephalon-Derived 
hNPCs 
 Isolation and propagation of hNPCs were done in accordance 
with the guidelines and approved by the local ethics committee 
and that of the University of Rostock. NPCs isolated from the 
ventral mesencephalon of an elective aborted human fetus at 8 
weeks gestational age were expanded in culture as described else-
where [Hovakimyan et al., 2006]. If not specified otherwise, all 
material used for cell culturing was obtained from Invitrogen. In 
brief, hNPCs from ventral midbrain were cultured as monolayers 
on poly- L -lysine [10   g/ml/cm/laminin-1 (2   g/ml/cm 2 ); Sigma] 
coated dishes or glass coverslips with 12 mm diameter (for im-
munocytochemistry) and incubated in a 95% air and 5% CO 2 
humidified atmosphere at 37 ° C in a serum-free cultivation
medium composed of Dulbecco’s modified Eagle’s medium 
(DMEM)/F12 medium mixture (1: 1, high glucose), supplement-
ed with transferrin (100 mg/ml), insulin (25 mg/ml), progester-
one (20 n M ), putrescine (62 m M ) and sodium selenite (30 n M ). 
Mitogenic stimulation was achieved by adding EGF (20 ng/ml; 
Sigma) and FGF-2 (20 ng/ml; Sigma). Half the growth medium 
was replenished every second day. Passaging was undertaken ev-
ery 8th to 10th day before reaching confluence, due to cell pro-
liferation and doubling of cell numbers per passage. Proliferating 
hNPCs were expanded as adherent cells on monolayers, in order 
to prevent differentiation of neuroepithelial cells as observed
in neurosphere preparations, at least for 6 months up to 19 pas-
sages.
 In vitro Predifferentiation for Transplantation 
 To allow organotypic neuroepithelial in vitro  differentiation, 
neurospheres were generated by cultivation of cells in serum-free 
proliferation medium, containing 20 ng/ml human EGF and 
FGF-2, in bacteriological (nonadherent) dishes for 6 days [Cam-
pos et al., 2004]. After 6 days, spheres were collected and tritu-
rated to generate single-cell suspensions (100,000 cells/  l DMEM) 
for transplantation purposes.
 In vitro Differentiation 
 DAergic capacity of hNPC-derived neurospheres was per-
formed by replating spheres on laminin/poly- L -lysine-coated tis-
sue glass coverslips (12 mm diameter) placed in culture dishes and 
a further incubation in DMEM/F12 supplemented with N2 (Sig-
ma) for 24 h.
 In vitro Cell Characterization 
 For in vitro analysis of neural progenitor phenotype or DAer-
gic capacity of the above-mentioned cells cultured on glass cover-
slips, immunoflurescent stainings against nestin (progenitor phe-
notype) or TH (pacemaker enzyme of DA synthesis as indicator 
for DAergic differentiation) were performed. Cells were fixed in 
3.7% paraformaldehyde for 1 h at room temperature and then 
rinsed 3 times in 0.1  M phosphate-buffered saline (PBS, pH 7.4) 
followed by a preincubation in PBS containing 3% bovine serum 
albumin (BSA), 0.05% Triton X-100 and 5% normal goat serum 
for 1 h. Primary antibodies (anti-nestin, 1: 500, mouse monoclo-
nal, Chemicon, or anti-TH, 1: 500, mouse monoclonal, Sigma) 
were solved in PBS containing 1% BSA and 0.025% Triton X-100 
and incubated overnight at 4 ° C. After 3 rinses in PBS, secondary 
antibodies (goat anti-mouse, CY3 conjugated, 1: 500; Dianova) 
were incubated for 3 h at room temperature followed by 3 rinses 
in PBS. Finally, sections were mounted on glass slides and embed-
ded in anti-fading fluorescence mounting medium (Vector Labo-
ratories) and covered by coverslips.
 In vivo Experiments 
 Animals 
 A total of 15 male Wistar rats weighing between 280 and 320 g 
at the beginning of the experiment were housed at 22  8 2 ° C un-
der a 12-hour light/dark cycle with free access to food and water. 
All animal-related procedures were conducted in accordance 
with NIH and local ethical guidelines and approved by the animal 
experimentation committee of the University of Rostock.
 Generation of Hemiparkinsonian Rats 
 Rats (n = 15) were deeply anesthetized with pentobarbital-Na + 
(45 mg/kg intraperitoneal) and unilaterally lesioned by an injec-
tion of 6-hydroxydopamine (6-OHDA-HCl; Sigma) into the right 
medial forebrain bundle [26   g/4   l, solved in 0.9% saline con-
taining 0.8 mg ascorbic acid (Merck), coordinates referring to IA: 
AP +6.7, ML –1.5, V +1.5] [Paxinos and Watson, 1998].
 Intrastriatal Cell Transplantation 
 Twelve weeks after the lesion, intrastriatal stereotaxic trans-
plantation was conducted on the successfully lesioned animals
(n = 15) by applying the microtransplantation technique [Nik-
khah et al., 1994]. Rats were randomly classified into 2 groups, 
transplanted with hNPCs (transplantation group) or vehicle 
(DMEM, sham control group).  The transplantation group (5 an-
imals) received about 100,000 viable hNPCs (1   l suspension) 
into the right striatum using the coordinates with reference to 
bregma: A = +0.5, L = –3.5, V = +5.5 [Paxinos and Watson, 1998]. 
At the same time point, the sham control group (10 rats) received 
an injection of vehicle alone (1   l DMEM) using the same coor-
dinates as for the transplantation group. Cells from the same pas-
sage and cell preparation were transplanted both in juvenile [Ho-
vakimyan et al., 2006] and adult animals. To obtain similar con-
ditions with our previous parallel transplantation study using 
these cells [Hovakimyan et al., 2006], no immunosuppression 
was performed.
 Behavioral Tests 
 Apomorphine-Induced Rotations 
 Ten weeks after the lesion, apomorphine-induced rotations 
(0.25 mg/kg, subcutaneous; Teclapharm) were monitored for 40 
min using an automated rotometer system according to Unger-
stedt and Arbuthnott [1970]. The time lapse of 10 weeks between 
lesioning and testing is necessary because it is widely accepted 
that the increase in DA receptors, that is, in consistence with the 
number of rotations, reaches its final plateau during this time 
[Schwarting and Huston, 1996]. All animals (n = 15) displayed 
more than 4 contralateral rotations/min, indicating a unilateral 
death of about 97% of the nigrostriatal DAergic neurons [Unger-
stedt and Arbuthnott, 1970] and, therefore, were used for the 
transplantation studies. Four, eight and twelve weeks following 
transplantation, the apomorphine-induced rotation test was 
again conducted for both groups.
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 Cylinder Test  
 This test was also conducted 10 weeks after the lesion and 12 
weeks after transplantation for the same groups, as described pre-
viously [Kirik et al., 2000; Hovakimyan et al., 2006]. At these time 
points, each rat was individually placed in a transparent glass cyl-
inder and videotaped. Twenty consequent wall contacts executed 
independently with the left or right forepaw were counted to de-
termine the percentage of left forepaw use.
 Tissue Processing and Analysis 
 Rats were injected with an overdose of pentobarbital (60 mg/
kg) and transcardially perfused with ice-cold 0.9% sodium chlo-
ride (50 ml), followed by 400 ml of 3.7% paraformaldehyde. Brains 
were immediately removed from the skull, postfixed for 4 h, and 
transferred into PBS containing 20% sucrose (overnight, 4 ° C). 
The cryoprotected brains were frozen in isopentane (–50  ° C) and 
stored at –80 ° C until further processing.
 Brains were cut with a cryostat at 30   m and serial sections 
were collected free-floating in PBS. To identify and map the 
grafts’ location, every seventh section was stained by the silver 
staining method as previously described by Gallyas et al. [1980]. 
For immunohistochemical analysis, sections were pretreated 
with 3% H 2 O 2 , blocked with 3% BSA, normal horse serum (1: 67, 
polyclonal; Vector Laboratories) and 0.05% Triton X-100 for 1 h at 
room temperature, and then incubated with mouse anti-human 
nuclei (HN, 1: 400, monoclonal; Chemicon), mouse anti-TH
(1: 1,000, monoclonal; Sigma) or mouse anti-OX-42 (1: 1,000, 
monoclonal; Chemicon) primary antibodies overnight at 4 ° C. 
This was followed by incubation with biotinylated horse anti-
mouse secondary antibody (1: 200; Vector) overnight at 4 ° C. The 
secondary antibody step was followed with avidin-biotin peroxi-
dase-conjugated complex (1: 50; Vector) for 2 h at room tempera-
ture; 0.02% 3,3  -diaminobenzidine (DAB) was used as a chromo-
gen for the visualization. Mounted sections were dehydrated in 
graded alcohols, followed by an incubation in xylol and finally 
embedded in DePeX mounting medium (Serva). 
 For immunofluorescent staining, blocking was performed 
with 3% BSA, 5% normal goat serum and 0.05% Triton X-100
(2 h). All sections were stained with HN antibody (anti-HN,
1: 200) paired with rabbit anti-neurofilament 200 kDa (NF 200,
1: 100; Sigma) or anti-glial fibrillary acidic protein (GFAP, 1: 100; 
Sigma). For antigen visualization, secondary antibodies conju-
gated with anti-mouse CY3 (goat polyclonal, red fluorescence,
1: 500; Dianova), anti-rabbit CY2 (donkey polyclonal, green fluo-
rescence, 1: 400; Dianova) or anti-rabbit AMCA (goat polyclonal, 
blue fluorescence, 1: 100; Dianova) were used. The sections stained 
with anti-HN and anti-GFAP (detected with Cy3- and AMCA-
conjugated antibodies) were further incubated with FITC-conju-
gated anti-NeuN (mouse-monoclonal, 1: 200; Chemicon).
 Statistical Analysis 
 Comparisons between groups were made using the nonpara-
metric Mann-Whitney U test in SPSS 11.01 (SPSS Inc.). The min-
imum level of statistical significance was set at p  ! 0.05. All data 
are expressed as means  8 SEM.
 Results 
 Characteristics of hNPCs in vitro  
 After proliferation and expansion for 19 passages, 
hNPCs continuously contained the neural progenitor 
marker nestin ( fig. 1 a) and the intermediate filament vi-
mentin as described elsewhere [Hovakimyan et al., 2006]. 
However, these cells were able to develop a considerable 
number of TH-ir neurons, when allowed to differentiate 
in vitro, indicating their DAergic differentiation capacity 
( fig. 1 b), independently of the number of passages.
 Behavioral Recovery of Hemiparkinsonian Rats 
 Apomorphine-induced rotations were counted as a 
marker for functional impairment ( fig. 2 a). In this test, 
all animals (n = 15) with a unilateral 6-OHDA lesion   dis-
played a robust initial rotation response to apomorphine 
10 weeks after lesioning, and there was no significant dif-
ference between the groups before grafting. The time 
lapse of 10 weeks between lesioning and testing was nec-
a b
 Fig. 1. In vitro morphology of hNPCs. Un-
differentiated hNPCs possess a flat neuro-
epithelial morphology and are nestin-ir 
( a ), whereas after differentiation as plated 
spheres ( b ) the cells show a neuronal mor-
phology with elongated processes and a 
moderate number express TH.  Scale bar:
a 10   m,  b 100   m. 
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essary because it is widely accepted that the number of 
rotations reaches its final plateau by this time [Schwar-
ting and Huston, 1996]. The rotation test was again per-
formed 4, 8 and 12 weeks following transplantation. In 
the transplantation group, rats showed a mild behavioral 
recovery. At 12 weeks after transplantation, the average 
rotation score was decreased from 9.10 to 8.55. In con-
trast, in the sham control group, rotations in the direc-
tion contralateral to the lesion significantly increased 
from 7.72 to 10.6 (p  ^  0.05).
 In the cylinder test, again a lesion became obvious by 
preferred right forepaw use ( fig. 2 b). For the sham control 
group 10 weeks after lesioning, the percentage of left fore-
paw use (left forepaw use ratio) was about 21%. Despite 
this ratio reaching about 38% at 12 weeks after transplan-
tation, it remained statistically significant, indicating 
only an incomplete recovery. In the transplantation group, 
again a preferred left forepaw use by about 25% became 
obvious 10 weeks after lesioning (p  ^  0.05). However, 12 
weeks after grafting, this group showed a forepaw use ra-
tio of about 48% that is similar to our observations for 
healthy animals [Hovakimyan et al., 2006].
 Assessment of DAergic Deafferentiation of the 
Striatum 
 The 6-OHDA lesions of the right nigrostriatal bundle 
produced, within 10 weeks, a nearly complete loss of 
DAergic neurons in the ipsilateral substantia nigra 
( fig. 3 a). Accordingly, the lack of TH-ir in the ipsilateral 
right striatum was also obvious ( fig. 3 b), whereas in the 
contralateral (left) striatum, a rich innervation by affer-
ent fibers from the contralateral intact substantia nigra 
remained visible in lesioned animals ( fig. 3 a, b). The
TH-ir in the sham control group was similar as in those 
animals only lesioned ( fig. 3 c). This was also the case for 
the transplantation group ( fig. 3 d).
 Cell Survival, Migration and Differentiation 
 The cell grafts could be easily identified   in brain sec-
tions following HN immunostaining ( fig. 4 a, b). No 
marked differences were observed in graft morphology 
or size between animals. By HN-ir, most transplanted 
cells were confined to the striatum ( fig. 4 a, b), scattered 
around the needle track, whereas a minority showed mi-
gration into the surrounding parenchyma. Under higher 
magnification, cells with nuclei of different size and mor-
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 Fig. 2.  a Motor asymmetry tests. Changes in apomorphine-in-
duced rotation balanced to initial rotation values of the sham con-
trol (left) and the transplantation group (right) 10 weeks after le-
sioning. Sham control animals (n = 10) displayed a significant
(p  ^  0.05) increase in rotations per minute (+2.88  8 1.05). In the 
transplantation group, the rotation number decreased from 9.10 
(after the lesion) to 8.55 rotations per minute (–0.55  8 0.72).
 b The cylinder test showed a significant impairment in the left 
forepaw use 10 weeks after lesioning for the sham control group 
(21  8 4.7, p  ^  0.05) and the transplantation group (25  8 7.58,
p  ^  0.05). Twelve weeks after grafting, the animals of the sham 
control group still revealed a significant left forepaw use prefer-
ence (38%  8 5.28% left; p  ^  0.05), whereas those of the trans-
plantation group showed a loss of forepaw preference (48%  8 
3.39% left forepaw use without any significance; p  1 0.05). 
*p  ^  0.05.
 Hovakimyan /Haas /Schmitt /Gerber /
Wree /Andressen 
Cells Tissues Organs6
phology could be discerned ( fig. 4 b). In transplanted an-
imals, we never observed tumor formation.
 DAB-labeled HN-ir cells were counted in serial sec-
tions to obtain an estimation of cell survival. The mean 
number of absolute cell counts of transplanted cells per 
striatum was 4,376  8 64.1, which was approximately 
4.4% of the total number of initially transplanted viable 
cells.
 Activation of microglia as a marker for inflammation 
was visualized by the morphology of OX-42-ir cells. Only 
moderate differences were found between the sham con-
trol and the transplantation group ( fig. 4 c, d). The major-
ity of stained cells revealed a ramified morphology, typi-
cally for their resting state. Only around the stab wound, 
OX-42-ir was more pronounced, probably due to the me-
chanical injury.
 Multipotent differentiation of grafted cells was con-
firmed by double immunofluorescent staining and con-
focal microscopy using HN ( fig. 5 a, d, g) paired with 
either NeuN ( fig. 5 b, e) or NF 200 (data not shown) or 
GFAP ( fig. 5 h). In accordance with the light microscopy 
observations, the immunofluorescence analysis again 
revealed a dense aggregate of HN-ir cells, located at the 
implantation site. Only a small number of cells migrated 
up to 600   m into the host parenchyma ( fig. 5 b, c). Nu-
merous neurons were identified by colabeling of HN 
( fig. 5 d) with NeuN ( fig. 5 e, f). In addition to neuronal 
differentiation, a certain number of cells containing HN 
a b
c d
 Fig. 3. TH-ir in frontal sections containing the region of the mid-
brain ( a ) or the striatum ( b–d ) of the various animal groups. Uni-
lateral 6-OHDA lesioning leads to a nearly complete loss of
DAergic neurons in the substantia nigra ( a ) and subsequently to 
a downregulation of TH-ir in the ipsilateral striatum ( b ) as shown 
10 weeks after lesion. In contrast, the unaffected contralateral 
substantia nigra contains intensely stained DAergic neurons ( a , 
right side) and a rich DAergic innervation of the striatum ( b , right 
side).  c Sham control animals show similar TH contents 12 weeks 
after sham transplantation, that is, 22 weeks after lesion.  d Rats 
grafted with hNPCs also possess a comparably low TH-ir in the 
lesioned and subsequently transplanted hemisphere. Scale bar:
 a 4,500   m,  b–d  2,000   m. 
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( fig. 5 g) was found to express the astroglial marker 
GFAP ( fig. 5 h, i). We observed that the number of graft-
ed cells expressing neuronal markers (NeuN or NF 200) 
was comparable with those expressing the astroglial 
marker GFAP.
 Discussion  
 It is generally accepted that the generation of large 
numbers of graftable neurons is an important prerequi-
site for a successful clinical treatment of PD. To fulfill this 
criterium, one possibility is the in vitro expansion of fetal 
hNPCs derived from the ventral midbrain. Recently, we 
have shown that such cells derived from human fetus can 
be expanded in culture for up to 6 months. When trans-
planted into the striatum of hemiparkinsonian juvenile 
rats, their differentiation into TH-ir neurons resulted in 
a significant motor behavior recovery [Hovakimyan et 
al., 2006]. Taking into account the view of the neonatal 
brain as a more permissive environment for neuronal dif-
ferentiation [Schwarz and Freed, 1987], in this parallel 
experiment we were interested in the integration and dif-
ferentiation capacity of these expanded hNPCs after 
a b
c d
 Fig. 4. Distribution of grafted cells stained 
for HN and host inflammation response 
revealed by OX-42-ir.  a Overview of a 
frontal section through the striatum shows 
the position of HN-ir-grafted cells (inset) 
by DAB visualization.  b By higher magni-
fication of the inset, mainly 2 phenotypes 
of HN-ir cell nuclei can be observed, round 
or elongated.  c Detection of OX-42-ir in 
transplanted animals reveals only a mod-
erate amount of immunoreactivity in the 
region of the injection tract, containing 
only single activated microglial cells.  d In 
sham-transplanted animals, a slight in-
crease in OX-42-ir is also detectable in the 
region of the stab wound, compared to the 
surrounding areas.  Scale bar: a 800   m, 
 b–d  100   m. 
 Hovakimyan /Haas /Schmitt /Gerber /
Wree /Andressen 
Cells Tissues Organs8
a b c
d e f
g h i
 Fig. 5. Survival, migration and differentiation of transplanted hNPCs in the rat striatum. Multipotential dif-
ferentation of transplanted hNPCs was evaluated by red fluorescent staining of HN ( a ,  d ,  g ) and green fluores-
cent labeling of NeuN ( b ,  e ) or GFAP ( h ), merged in  c ,  f or  i using confocal laser scanning microscopy. By high-
power magnification, double-labeled neurons ( f , yellow-orange fluorescence) or astrocytes ( i , arrows) can be 
clearly discerned. Scale bar:  a–c 125   m,  d–i 18   m. 
 Dopamine-Independent Recovery in 
Experimental Parkinson’s Disease 
Cells Tissues Organs 9
transplantation into the 6-OHDA-lesioned striatum of 
adult rats, focusing our attention on the DAergic differ-
entiation and functional effects.
 Fate of Transplanted Cells 
 Concerning differences between the characteristics of 
cells grafted into either neonatal or adult rat striatum, the 
most striking observation is the total absence of TH-ir 
cells in the striatum of adult animals, suggesting selective 
effects on the DAergic differentiation by the adult envi-
ronment. This observation is in good agreement with a 
recent report on transplantation of expanded ventral 
mesencephalic hNPCs from a 12-week-old fetus into the 
hemiparkinsonian adult rat striatum [Wang et al., 2004]. 
In contrast, Svendsen et al. [1997] reported on the differ-
entiation of hNPC-derived neurons that expressed TH at 
very low numbers and were sufficient to partially amelio-
rate lesion-induced behavioral deficits in only 2 animals. 
Interestingly, in this case the precursor cell population 
was from mixed brain regions. This might be of impor-
tance, since it is well known that DA-containing neurons 
are present in various areas of the CNS including the tel-
encephalon [Bear et al., 2001]. Therefore, one can specu-
late whether hNPCs of nonmesencephalic, for example 
telencephalic, origin display a better DAergic differentia-
tion capacity after intrastriatal transplantation.
 The limited ability of prosencephalic or mesencephal-
ic progenitors to differentiate into DAergic neurons in the 
mature host brain [Wang et al., 2004; Christophersen et 
al., 2006] highlights a general problem of transplanted 
NPCs to become committed to a certain neuronal lineage. 
Since our results show that like in juveniles, high numbers 
of neurons as well as GFAP-ir glial cells derived from 
transplanted cells were found in adult recipients, the 
knowledge about differences between the adult and juve-
nile striatum, selectively affecting certain lines of neuro-
nal, especially DAergic differentiation, are truly of tre-
mendous importance for the optimization of the cell re-
placement therapy for PD. However, unbiased stereology, 
concerning neuronal or glial differentiation, has not been 
performed due to technical limitations and, therefore, 
these observations have to be considered as preliminary.
 Functional Effects 
 Despite the lack of TH-ir cells in striatum following 
transplantation, a therapeutic effect was observed in ani-
mals of the transplantation group when compared to the 
sham control group, indicating that additional factors 
have to be responsible for the observed functional recov-
ery. This is in agreement with a recent study evaluating 
the effects of neurotrophic factors like glial cell line-de-
rived neurotrophic factor (GDNF) both in humans [Gill 
et al., 2003] and nonhuman primates [Grondin et al., 
2002]. In the latter study, a significant recovery in behav-
ior is paralleled by only a small increase in mean striatal 
DA levels, suggesting a functional plasticity in the basal 
ganglia beyond a mere DA innervation [Brundin, 2002]. 
In this context, it is noteworthy that in our study, a con-
siderable portion of cells underwent differentiation in the 
astroglial direction, as shown by double immunofluores-
cence for HN and astroglial marker GFAP. It seems like-
ly that these cells might express GDNF or other neuro-
trophic factors that have been shown to be involved in a 
functional recovery in animal models of PD [Yoshimoto 
et al., 1995; Gash et al., 1996; Chaturvedi et al., 2006;
McCoy et al., 2006]. This speculation is based on the evi-
dence that NPCs can express GDNF and other neuro-
trophic factors not only in vitro, but also after grafting 
into adult CNS [Lu et al., 2003; Gao et al., 2006]. Alterna-
tively, grafted cells could give rise to another type of neu-
rons, e.g.   -aminobutyric acid expressing, which could 
lead to perturbations in other neurotransmitter systems, 
contributing partially to the behavioral recovery [Wink-
ler et al., 1999]. The fact remains that unknown factors 
are responsible for the improvement in motor behavior. 
Further investigations are required to determine the na-
ture of these factors.
 Regarding our results, it is notable that the release of 
neuroprotective factors by activated microglia [Nagatsu 
and Sawada, 2006] has to be ruled out because both in the 
transplanted as well as in the sham-operated animals the 
vast majority of OX-42-ir cells exhibited the typical ram-
ified resting stage morphology [Kreutzberg, 1996]. Only 
a small number of partially activated cells with a rod-like 
shape were detected, preferentially located around the 
needle track, probably caused by mechanical injury. Con-
sequently, observed behavioral differences between the 2 
groups have to be referred to the grafted hNPCs.
 Concluding Remarks 
 In conclusion, our results show that, despite immuno-
suppression, considerable numbers of neurons and glial 
cells derived from transplanted hNPCs were found for up 
to 12 weeks after transplantation. However, in contrast to 
juveniles, hNPCs grafted in adult animals did not give 
rise to TH-ir neurons. Despite their lack in the trans-
plants, we observed a mild therapeutic effect in the apo-
morphine-induced rotation test. A more obvious effect 
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was detected in the cylinder test. Since both NeuN-ir 
neuronal and GFAP-ir glial differentiation of transplant-
ed cells was detected in similar amounts in juvenile as 
well as adult recipients, we suggest local factors of the en-
vironment of adult rats, affecting selectively certain lines 
of neuronal, especially a DAergic differentiation. There-
fore, in accordance with Brundin et al. [2000a] and Gron-
din et al. [2002], we propose that not only a reconstitution 
of a DAergic innervation, but additional yet unknown 
factors should be taken into account for the development 
of cell replacement therapies for PD.
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